Evaluating testicular function changes in unilateral cryptorchid chinese infants underwent orchidopexy in the first year of life

OBJECTIVE

Management of cryptorchidism is typically recommended within the first 18 months of life to maximize fertility potential. However, there is a paucity of longitudinal postoperative data for Chinese infants. We aim to evaluate the Testicular function change when the procedure is done within the first year of life.

METHOD

We prospectively enrolled 51 children diagnosed with unilateral inguinal cryptorchidism into the surgical group between January 2021 and January 2022. Orchidopexy was carried out through a single transverse scrotal incision. Assessments of anti-Mullerian hormone (AMH), inhibin B (InhB), testosterone (T) levels, testicular volume and testicular atrophy index (TAI) were conducted at baseline, 6 months, and 1 year following surgery. Concurrently, clinical data from 42 healthy age-matched controls were collected during their routine physical examinations.

RESULTS

At 6- and 12-months post-surgery, testicular volume increased significantly to 0.98 ± 0.12 mL and 1.01 ± 0.12ml. AMH levels also rose from 76.40 ± 15.77 ng/mL to 81.52 ± 15.32 ng/mL and 87.50 ± 15.36 ng/mL. However, these parameters are significantly lower than age-matched healthy controls (both P < 0.001). InhB levels significantly increased after surgery and even surpassed those of healthy controls after 6 months (both P < 0.001). The TAI was 16.7% and 8.6% at 6- and 12-months following surgery.

CONCLUSION

Although orchiopexy can improve testicular growth and function, the restoration of testicular function to the level of healthy peers might take longer. To expedite the recovery of testicular function and bring it in line with that of peers, we recommend addressing cryptorchidism at the earliest opportunity.

Transconjunctival Fat Repositioning Blepharoplasty: Is Excess Fat Herniation a Prerequisite?

BACKGROUND

The fat repositioning technique has been widely used for the treatment of tear trough deformity, and there is a strong belief that excess fat herniation is a prerequisite for the procedure. The purpose of this study was to evaluate its effect in patients with minimal or no excess fat herniation.

METHODS

A total of 232 patients underwent the procedure and met the inclusion criteria. Of them, 198 were primary cases, and 34 had a hisory of fat removal for blepharoplasty. The amount of infraorbital fat was evaluated preoperatively by palpation. Release of the tear trough ligament and fat redistribution were sequentially performed as described previously. Surgical outcome was assessed based on the Hirmand grading system and the FACE-Q scales.

RESULTS

Tear trough deformities were eliminated in more than 85% of cases. Aesthetic results were comparable between the primary and secondary surgery groups. The percentage of patients who complained of extremely or moderately severe tear trough deformities decreased from 86.3% preoperatively to 34.0% postoperatively. The scores of the lower eyelid FACE-Q decreased significantly ( P < 0.05). Patients were satisfied with their decision to undergo blepharoplasty (78.2 ± 18.7). Undercorrection of the tear trough occurred in 30 patients. Other complications included 12 cases of transient conjunctiva bleeding, two cases of eyelid numbness, and six cases of dry eye. These resolved spontaneously.

CONCLUSION

Fat repositioning is a feasible and effective technique for the treatment of tear trough deformities in patients with minimal or no excess orbital fat herniation, provided that a fat pad is palpable.

CLINICAL QUESTION/LEVEL OF EVIDENCE

Therapeutic, IV.

Electrospun Aligned Nanofiber Yarns Constructed Biomimetic M-Type Interface Integrated into Precise Co-Culture System as Muscle-Tendon Junction-on-a-Chip for Drug Development

The incorporation of engineered muscle-tendon junction (MTJ) with organ-on-a-chip technology provides promising in vitro models for the understanding of cell-cell interaction at the interface between muscle and tendon tissues. However, developing engineered MTJ tissue with biomimetic anatomical interface structure remains challenging, and the precise co-culture of engineered interface tissue is further regarded as a remarkable obstacle. Herein, an interwoven waving approach is presented to develop engineered MTJ tissue with a biomimetic "M-type" interface structure, and further integrated into a precise co-culture microfluidic device for functional MTJ-on-a-chip fabrication. These multiscale MTJ scaffolds based on electrospun nanofiber yarns enabled 3D cellular alignment and differentiation, and the "M-type" structure led to cellular organization and interaction at the interface zone. Crucially, a compartmentalized co-culture system is integrated into an MTJ-on-a-chip device for the precise co-culture of muscle and tendon zones using their medium at the same time. Such an MTJ-on-a-chip device is further served for drug-associated MTJ toxic or protective efficacy investigations. These results highlight that these interwoven nanofibrous scaffolds with biomimetic "M-type" interface are beneficial for engineered MTJ tissue development, and MTJ-on-a-chip with precise co-culture system indicated their promising potential as in vitro musculoskeletal models for drug development and biological mechanism studies.

Development of a 50 kV hydrogen-helium mixed ion beam implanter

Ion implanters have extensively been employed to simulate the irradiation effects of neutrons on relevant nuclear materials. In this study, a 50 kV hydrogen-helium mixed ion beam implanter was developed to generate H2+ and He+ ion beams, with a beam current of 20 µA, while keeping the impurity ion content below 2%. The ions are generated by an antenna-type 2.45 GHz electron cyclotron resonance ion source, and the hydrogen-to-helium ion beam ratio was controlled using two gas mass flow controllers to ensure long time stability of the beam current. As a result, the H2+/He+ ratio, beam size, and homogeneity of the beam spot can be maintained at a stable level. The beam line consisted of four Wien filters, a movable dual-slit plate, and an accelerator tube. The experimental results demonstrated successful transport of more than 20 µA of H2+ and He+ ion beams onto the target, with a beam axis deviation of less than 0.5 mm.

The incidence of surgical site infections in China

Surgical site infections (SSIs) are a common type of healthcare-associated infection. We performed a literature review to demonstrate the incidence of SSIs in mainland China based on studies since 2010. We included 231 eligible studies with ≥30 postoperative patients, comprising 14 providing overall SSI data regardless of surgical sites and 217 reporting SSIs for a specific site. We found that the overall SSI incidence was 2.91% (median; interquartile range: 1.05%, 4.57%) or 3.18% (pooled; 95% confidence interval: 1.85%, 4.51%) and the SSI incidence varied remarkably according to the surgical site between the lowest (median, 1.00%; pooled, 1.69%) in thyroid surgeries and the highest (median, 14.89%; pooled, 12.54%) in colorectal procedures. We uncovered that Enterobacterales and staphylococci were the most common types of micro-organisms associated with SSIs after various abdominal surgeries and cardiac or neurological procedures, respectively. We identified two, nine, and five studies addressing the impact of SSIs on mortality, the length of stay (LOS) in hospital, and additional healthcare-related economic burden, respectively, all of which demonstrated increased mortality, prolonged LOS, and elevated medical costs associated with SSIs among affected patients. Our findings illustrate that SSIs remain a relatively common, serious threat to patient safety in China, requiring more action. To tackle SSIs, we propose to establish a nationwide network for SSI surveillance using unified criteria with the aid of informatic techniques and to tailor and implement countermeasures based on local data and observation. We highlight that the impact of SSIs in China warrants further study.

Amplitude Analysis of the B^{0}→K^{*0}μ^{+}μ^{-} Decay

An amplitude analysis of the B^{0}→K^{*0}μ^{+}μ^{-} decay is presented using a dataset corresponding to an integrated luminosity of 4.7  fb^{-1} of pp collision data collected with the LHCb experiment. For the first time, the coefficients associated to short-distance physics effects, sensitive to processes beyond the standard model, are extracted directly from the data through a q^{2}-unbinned amplitude analysis, where q^{2} is the μ^{+}μ^{-} invariant mass squared. Long-distance contributions, which originate from nonfactorizable QCD processes, are systematically investigated, and the most accurate assessment to date of their impact on the physical observables is obtained. The pattern of measured corrections to the short-distance couplings is found to be consistent with previous analyses of b- to s-quark transitions, with the largest discrepancy from the standard model predictions found to be at the level of 1.8 standard deviations. The global significance of the observed differences in the decay is 1.4 standard deviations.

Detection of HER2 expression using 99mTc-NM-02 nanobody in patients with breast cancer: a non-randomized, non-blinded clinical trial

BACKGROUND

99mTc radiolabeled nanobody NM-02 (99mTc-NM-02) is a novel single photon emission computed tomography (SPECT) probe with a high affinity and specificity for human epidermal growth factor receptor 2 (HER2). In this study, a clinical imaging trial was conducted to investigate the relationship between 99mTc-NM-02 uptake and HER2 expression in patients with breast cancer.

METHODS

Thirty patients with pathologically confirmed breast cancer were recruited and imaged with both 99mTc-NM-02 SPECT/computed tomography (CT) and 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/CT. According to the treatment conditions before recruitment, patients were divided into two groups, the newly diagnosed group (n = 24) and the treated group (n = 6). The maximal standard uptake value (SUVmax) of 18F-FDG and SUVmax and mean SUV (SUVmean) of 99mTc-NM-02 in the lesions were determined to analyze the relationship with HER2 expression.

RESULTS

No meaningful relationship was observed between 18F-FDG uptake and HER2 expression in 30 patients with breast cancer. 99mTc-NM-02 uptake was positively correlated with HER2 expression in the newly diagnosed group, but no correlation was observed in the treated group. 99mTc-NM-02 uptake in HER2-positive lesions was lower in those with effective HER2-targeted therapy compared with the newly diagnosed group. 99mTc-NM-02 SPECT/CT detected brain and bone metastases of breast cancer with a different imaging pattern from 18F-FDG PET/CT. 99mTc-NM-02 showed no non-specific uptake in inflamed tissues and revealed intra- and intertumoral HER2 heterogeneity by SPECT/CT imaging in 9 of the 30 patients with breast cancer.

CONCLUSIONS

99mTc-NM-02 SPECT/CT has the potential for visualizing whole-body HER2 overexpression in untreated patients, making it a promising method for HER2 assessment in patients with breast cancer.

TRIAL REGISTRATION

NCT04674722, Date of registration: December 19, 2020.

Fraction of χ_{c} Decays in Prompt J/ψ Production Measured in pPb Collisions at sqrt[s_{NN}]=8.16 TeV

The fraction of χ_{c1} and χ_{c2} decays in the prompt J/ψ yield, F_{χ_{c}→J/ψ}=σ_{χ_{c}→J/ψ}/σ_{J/ψ}, is measured by the LHCb detector in pPb collisions at sqrt[s_{NN}]=8.16  TeV. The study covers the forward (1.5 Collapse

Key Words Collapse

MESH Headings Collapse

Grants Collapse

Affiliation(s)

R Aaij Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
A S W Abdelmotteleb Department of Physics, University of Warwick, Coventry, United Kingdom
C Abellan Beteta Physik-Institut, Universität Zürich, Zürich, Switzerland
F Abudinén Department of Physics, University of Warwick, Coventry, United Kingdom
T Ackernley Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
B Adeva Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
M Adinolfi H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
P Adlarson Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
C Agapopoulou European Organization for Nuclear Research (CERN), Geneva, Switzerland
C A Aidala University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
Z Ajaltouni Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
S Akar University of Cincinnati, Cincinnati, Ohio, USA
K Akiba Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
P Albicocco INFN Laboratori Nazionali di Frascati, Frascati, Italy
J Albrecht Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
F Alessio European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Alexander School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A Alfonso Albero ICCUB, Universitat de Barcelona, Barcelona, Spain
Z Aliouche Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
P Alvarez Cartelle Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
R Amalric LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
S Amato Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
J L Amey H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
Y Amhis Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France European Organization for Nuclear Research (CERN), Geneva, Switzerland
L An School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
L Anderlini INFN Sezione di Firenze, Firenze, Italy
M Andersson Physik-Institut, Universität Zürich, Zürich, Switzerland
A Andreianov Affiliated with an institute covered by a cooperation agreement with CERN
P Andreola Physik-Institut, Universität Zürich, Zürich, Switzerland
M Andreotti INFN Sezione di Ferrara, Ferrara, Italy
D Andreou Syracuse University, Syracuse, New York, USA
A A Anelli INFN Sezione di Milano-Bicocca, Milano, Italy
D Ao University of Chinese Academy of Sciences, Beijing, China
F Archilli INFN Sezione di Roma Tor Vergata, Roma, Italy
M Argenton INFN Sezione di Ferrara, Ferrara, Italy
S Arguedas Cuendis Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica
A Artamonov Affiliated with an institute covered by a cooperation agreement with CERN
M Artuso Syracuse University, Syracuse, New York, USA
E Aslanides Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
M Atzeni Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
B Audurier Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
D Bacher Department of Physics, University of Oxford, Oxford, United Kingdom
I Bachiller Perea Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
S Bachmann Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M Bachmayer Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J J Back Department of Physics, University of Warwick, Coventry, United Kingdom
A Bailly-Reyre LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
P Baladron Rodriguez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
V Balagura Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
W Baldini INFN Sezione di Ferrara, Ferrara, Italy
J Baptista de Souza Leite Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
M Barbetti INFN Sezione di Firenze, Firenze, Italy
I R Barbosa Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
R J Barlow Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
S Barsuk Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
W Barter School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Bartolini Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
F Baryshnikov Affiliated with an institute covered by a cooperation agreement with CERN
J M Basels I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
G Bassi INFN Sezione di Pisa, Pisa, Italy
B Batsukh Institute Of High Energy Physics (IHEP), Beijing, China
A Battig Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
A Bay Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
A Beck Department of Physics, University of Warwick, Coventry, United Kingdom
M Becker Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
F Bedeschi INFN Sezione di Pisa, Pisa, Italy
I B Bediaga Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
A Beiter Syracuse University, Syracuse, New York, USA
S Belin Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
V Bellee Physik-Institut, Universität Zürich, Zürich, Switzerland
K Belous Affiliated with an institute covered by a cooperation agreement with CERN
I Belov INFN Sezione di Genova, Genova, Italy
I Belyaev Affiliated with an institute covered by a cooperation agreement with CERN
G Benane Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
G Bencivenni INFN Laboratori Nazionali di Frascati, Frascati, Italy
E Ben-Haim LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
A Berezhnoy Affiliated with an institute covered by a cooperation agreement with CERN
R Bernet Physik-Institut, Universität Zürich, Zürich, Switzerland
S Bernet Andres DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
H C Bernstein Syracuse University, Syracuse, New York, USA
C Bertella Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
A Bertolin Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
C Betancourt Physik-Institut, Universität Zürich, Zürich, Switzerland
F Betti School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
J Bex Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
Ia Bezshyiko Physik-Institut, Universität Zürich, Zürich, Switzerland
J Bhom Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
M S Bieker Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
N V Biesuz INFN Sezione di Ferrara, Ferrara, Italy
P Billoir LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
A Biolchini Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
M Birch Imperial College London, London, United Kingdom
F C R Bishop Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
A Bitadze Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
A Bizzeti School of Physics and Astronomy, Monash University, Melbourne, Australia Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil Center for High Energy Physics, Tsinghua University, Beijing, China Institute Of High Energy Physics (IHEP), Beijing, China School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China University of Chinese Academy of Sciences, Beijing, China Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany School of Physics, University College Dublin, Dublin, Ireland INFN Sezione di Bari, Bari, Italy INFN Sezione di Bologna, Bologna, Italy INFN Sezione di Ferrara, Ferrara, Italy INFN Sezione di Firenze, Firenze, Italy INFN Laboratori Nazionali di Frascati, Frascati, Italy INFN Sezione di Genova, Genova, Italy INFN Sezione di Milano, Milano, Italy INFN Sezione di Milano-Bicocca, Milano, Italy INFN Sezione di Cagliari, Monserrato, Italy Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy INFN Sezione di Perugia, Perugia, Italy INFN Sezione di Pisa, Pisa, Italy INFN Sezione di Roma La Sapienza, Roma, Italy INFN Sezione di Roma Tor Vergata, Roma, Italy Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland National Center for Nuclear Research (NCBJ), Warsaw, Poland Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania Affiliated with an institute covered by a cooperation agreement with CERN DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain ICCUB, Universitat de Barcelona, Barcelona, Spain Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain European Organization for Nuclear Research (CERN), Geneva, Switzerland Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland Physik-Institut, Universität Zürich, Zürich, Switzerland NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine University of Birmingham, Birmingham, United Kingdom H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom Department of Physics, University of Warwick, Coventry, United Kingdom STFC Rutherford Appleton Laboratory, Didcot, United Kingdom School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom Imperial College London, London, United Kingdom Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom Department of Physics, University of Oxford, Oxford, United Kingdom Massachusetts Institute of Technology, Cambridge, Massachusetts, USA University of Cincinnati, Cincinnati, Ohio, USA University of Maryland, College Park, Maryland, USA Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA Syracuse University, Syracuse, New York, USA Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil) School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China) Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China) School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France) Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany) Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland) Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland) Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom) University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA) Departement de Physique Nucleaire (SPhN), Gif-Sur-Yvette, France
M P Blago Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
T Blake Department of Physics, University of Warwick, Coventry, United Kingdom
F Blanc Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J E Blank Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
S Blusk Syracuse University, Syracuse, New York, USA
D Bobulska School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
V Bocharnikov Affiliated with an institute covered by a cooperation agreement with CERN
J A Boelhauve Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
O Boente Garcia Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
T Boettcher University of Cincinnati, Cincinnati, Ohio, USA
A Bohare School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
A Boldyrev Affiliated with an institute covered by a cooperation agreement with CERN
C S Bolognani Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
R Bolzonella INFN Sezione di Ferrara, Ferrara, Italy
N Bondar Affiliated with an institute covered by a cooperation agreement with CERN
F Borgato Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Borghi Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M Borsato INFN Sezione di Milano-Bicocca, Milano, Italy
J T Borsuk Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
S A Bouchiba Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
T J V Bowcock Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
A Boyer European Organization for Nuclear Research (CERN), Geneva, Switzerland
C Bozzi INFN Sezione di Ferrara, Ferrara, Italy
M J Bradley Imperial College London, London, United Kingdom
S Braun University of Maryland, College Park, Maryland, USA
A Brea Rodriguez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
N Breer Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J Brodzicka Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
A Brossa Gonzalo Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
J Brown Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
D Brundu INFN Sezione di Cagliari, Monserrato, Italy
A Buonaura Physik-Institut, Universität Zürich, Zürich, Switzerland
L Buonincontri Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
A T Burke Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
C Burr European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Bursche Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
A Butkevich Affiliated with an institute covered by a cooperation agreement with CERN
J S Butter Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
J Buytaert European Organization for Nuclear Research (CERN), Geneva, Switzerland
W Byczynski European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Cadeddu INFN Sezione di Cagliari, Monserrato, Italy
H Cai School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
R Calabrese INFN Sezione di Ferrara, Ferrara, Italy
L Calefice Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
S Cali INFN Laboratori Nazionali di Frascati, Frascati, Italy
M Calvi INFN Sezione di Milano-Bicocca, Milano, Italy
M Calvo Gomez DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
J Cambon Bouzas Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
P Campana INFN Laboratori Nazionali di Frascati, Frascati, Italy
D H Campora Perez Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
A F Campoverde Quezada University of Chinese Academy of Sciences, Beijing, China
S Capelli INFN Sezione di Milano-Bicocca, Milano, Italy
L Capriotti INFN Sezione di Ferrara, Ferrara, Italy
R Caravaca-Mora Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica
A Carbone INFN Sezione di Bologna, Bologna, Italy
L Carcedo Salgado Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
R Cardinale INFN Sezione di Genova, Genova, Italy
A Cardini INFN Sezione di Cagliari, Monserrato, Italy
P Carniti INFN Sezione di Milano-Bicocca, Milano, Italy
L Carus Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Casais Vidal Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
R Caspary Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
G Casse Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
J Castro Godinez Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica
M Cattaneo European Organization for Nuclear Research (CERN), Geneva, Switzerland
G Cavallero INFN Sezione di Ferrara, Ferrara, Italy
V Cavallini INFN Sezione di Ferrara, Ferrara, Italy
S Celani Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J Cerasoli Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
D Cervenkov Department of Physics, University of Oxford, Oxford, United Kingdom
S Cesare INFN Sezione di Milano, Milano, Italy
A J Chadwick Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
I Chahrour University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
M Charles LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
Ph Charpentier European Organization for Nuclear Research (CERN), Geneva, Switzerland
C A Chavez Barajas Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
M Chefdeville Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
C Chen Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
S Chen Institute Of High Energy Physics (IHEP), Beijing, China
A Chernov Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
S Chernyshenko Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
V Chobanova Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
S Cholak Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Chrzaszcz Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
A Chubykin Affiliated with an institute covered by a cooperation agreement with CERN
V Chulikov Affiliated with an institute covered by a cooperation agreement with CERN
P Ciambrone INFN Laboratori Nazionali di Frascati, Frascati, Italy
M F Cicala Department of Physics, University of Warwick, Coventry, United Kingdom
X Cid Vidal Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G Ciezarek European Organization for Nuclear Research (CERN), Geneva, Switzerland
P Cifra European Organization for Nuclear Research (CERN), Geneva, Switzerland
P E L Clarke School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Clemencic European Organization for Nuclear Research (CERN), Geneva, Switzerland
H V Cliff Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
J Closier European Organization for Nuclear Research (CERN), Geneva, Switzerland
J L Cobbledick Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
C Cocha Toapaxi Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
V Coco European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Cogan Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
E Cogneras Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
L Cojocariu Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
P Collins European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Colombo European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Comerma-Montells ICCUB, Universitat de Barcelona, Barcelona, Spain
L Congedo INFN Sezione di Bari, Bari, Italy
A Contu INFN Sezione di Cagliari, Monserrato, Italy
N Cooke School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
I Corredoira Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A Correia LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
G Corti European Organization for Nuclear Research (CERN), Geneva, Switzerland
J J Cottee Meldrum H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
B Couturier European Organization for Nuclear Research (CERN), Geneva, Switzerland
D C Craik Physik-Institut, Universität Zürich, Zürich, Switzerland
M Cruz Torres Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
R Currie School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
C L Da Silva Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
S Dadabaev Affiliated with an institute covered by a cooperation agreement with CERN
L Dai School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
X Dai School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
E Dall'Occo Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J Dalseno Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
C D'Ambrosio European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Daniel Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
A Danilina Affiliated with an institute covered by a cooperation agreement with CERN
P d'Argent INFN Sezione di Bari, Bari, Italy
A Davidson Department of Physics, University of Warwick, Coventry, United Kingdom
J E Davies Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
A Davis Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
O De Aguiar Francisco Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
C De Angelis INFN Sezione di Cagliari, Monserrato, Italy
J de Boer Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
K De Bruyn Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
S De Capua Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M De Cian Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany European Organization for Nuclear Research (CERN), Geneva, Switzerland
U De Freitas Carneiro Da Graca Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
E De Lucia INFN Laboratori Nazionali di Frascati, Frascati, Italy
J M De Miranda Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
L De Paula Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
M De Serio INFN Sezione di Bari, Bari, Italy
D De Simone Physik-Institut, Universität Zürich, Zürich, Switzerland
P De Simone INFN Laboratori Nazionali di Frascati, Frascati, Italy
F De Vellis Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J A de Vries Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
F Debernardis INFN Sezione di Bari, Bari, Italy
D Decamp Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
V Dedu Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
L Del Buono LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
B Delaney Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
H-P Dembinski Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J Deng Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
V Denysenko Physik-Institut, Universität Zürich, Zürich, Switzerland
O Deschamps Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
F Dettori INFN Sezione di Cagliari, Monserrato, Italy
B Dey Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland)
P Di Nezza INFN Laboratori Nazionali di Frascati, Frascati, Italy
I Diachkov Affiliated with an institute covered by a cooperation agreement with CERN
S Didenko Affiliated with an institute covered by a cooperation agreement with CERN
S Ding Syracuse University, Syracuse, New York, USA
V Dobishuk Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
A D Docheva School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A Dolmatov Affiliated with an institute covered by a cooperation agreement with CERN
C Dong Center for High Energy Physics, Tsinghua University, Beijing, China
A M Donohoe School of Physics, University College Dublin, Dublin, Ireland
F Dordei INFN Sezione di Cagliari, Monserrato, Italy
A C Dos Reis Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
L Douglas School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A G Downes Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
W Duan Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
P Duda Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
M W Dudek Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
L Dufour European Organization for Nuclear Research (CERN), Geneva, Switzerland
V Duk INFN Sezione di Perugia, Perugia, Italy
P Durante European Organization for Nuclear Research (CERN), Geneva, Switzerland
M M Duras Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
J M Durham Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
A Dziurda Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
A Dzyuba Affiliated with an institute covered by a cooperation agreement with CERN
S Easo European Organization for Nuclear Research (CERN), Geneva, Switzerland STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
E Eckstein Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
U Egede School of Physics and Astronomy, Monash University, Melbourne, Australia
A Egorychev Affiliated with an institute covered by a cooperation agreement with CERN
V Egorychev Affiliated with an institute covered by a cooperation agreement with CERN
C Eirea Orro Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
S Eisenhardt School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
E Ejopu Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
S Ek-In Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
L Eklund Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
M Elashri University of Cincinnati, Cincinnati, Ohio, USA
J Ellbracht Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
S Ely Imperial College London, London, United Kingdom
A Ene Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
E Epple University of Cincinnati, Cincinnati, Ohio, USA
S Escher I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
J Eschle Physik-Institut, Universität Zürich, Zürich, Switzerland
S Esen Physik-Institut, Universität Zürich, Zürich, Switzerland
T Evans Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
F Fabiano INFN Sezione di Cagliari, Monserrato, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
L N Falcao Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
Y Fan University of Chinese Academy of Sciences, Beijing, China
B Fang Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
L Fantini INFN Sezione di Perugia, Perugia, Italy
M Faria Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
K Farmer School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
D Fazzini INFN Sezione di Milano-Bicocca, Milano, Italy
L Felkowski Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
M Feng Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
M Feo European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Fernandez Gomez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A D Fernez University of Maryland, College Park, Maryland, USA
F Ferrari INFN Sezione di Bologna, Bologna, Italy
F Ferreira Rodrigues Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
S Ferreres Sole Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
M Ferrillo Physik-Institut, Universität Zürich, Zürich, Switzerland
M Ferro-Luzzi European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Filippov Affiliated with an institute covered by a cooperation agreement with CERN
R A Fini INFN Sezione di Bari, Bari, Italy
M Fiorini INFN Sezione di Ferrara, Ferrara, Italy
M Firlej AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
K M Fischer Department of Physics, University of Oxford, Oxford, United Kingdom
D S Fitzgerald University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
C Fitzpatrick Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
T Fiutowski AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
F Fleuret Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
M Fontana INFN Sezione di Bologna, Bologna, Italy
F Fontanelli INFN Sezione di Genova, Genova, Italy
L F Foreman Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
R Forty European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Foulds-Holt Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
M Franco Sevilla University of Maryland, College Park, Maryland, USA
M Frank European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Franzoso INFN Sezione di Ferrara, Ferrara, Italy
G Frau Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
C Frei European Organization for Nuclear Research (CERN), Geneva, Switzerland
D A Friday Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
L Frontini INFN Sezione di Milano, Milano, Italy
J Fu University of Chinese Academy of Sciences, Beijing, China
Q Fuehring Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
Y Fujii School of Physics and Astronomy, Monash University, Melbourne, Australia
T Fulghesu LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
E Gabriel Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
G Galati INFN Sezione di Bari, Bari, Italy
M D Galati Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
A Gallas Torreira Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
D Galli INFN Sezione di Bologna, Bologna, Italy
S Gambetta European Organization for Nuclear Research (CERN), Geneva, Switzerland School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Gandelman Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
P Gandini INFN Sezione di Milano, Milano, Italy
H Gao University of Chinese Academy of Sciences, Beijing, China
R Gao Department of Physics, University of Oxford, Oxford, United Kingdom
Y Gao Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Gao School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Y Gao Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
M Garau INFN Sezione di Cagliari, Monserrato, Italy
L M Garcia Martin Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
P Garcia Moreno ICCUB, Universitat de Barcelona, Barcelona, Spain
J García Pardiñas European Organization for Nuclear Research (CERN), Geneva, Switzerland
B Garcia Plana Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
K G Garg Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
L Garrido ICCUB, Universitat de Barcelona, Barcelona, Spain
C Gaspar European Organization for Nuclear Research (CERN), Geneva, Switzerland
R E Geertsema Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
L L Gerken Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
E Gersabeck Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M Gersabeck Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
T Gershon Department of Physics, University of Warwick, Coventry, United Kingdom
Z Ghorbanimoghaddam H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
L Giambastiani Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
F I Giasemis LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
V Gibson Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
H K Giemza National Center for Nuclear Research (NCBJ), Warsaw, Poland
A L Gilman Department of Physics, University of Oxford, Oxford, United Kingdom
M Giovannetti INFN Laboratori Nazionali di Frascati, Frascati, Italy
A Gioventù ICCUB, Universitat de Barcelona, Barcelona, Spain
P Gironella Gironell ICCUB, Universitat de Barcelona, Barcelona, Spain
C Giugliano INFN Sezione di Ferrara, Ferrara, Italy
M A Giza Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
E L Gkougkousis Imperial College London, London, United Kingdom
F C Glaser Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
V V Gligorov LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
C Göbel Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
E Golobardes DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
D Golubkov Affiliated with an institute covered by a cooperation agreement with CERN
A Golutvin Affiliated with an institute covered by a cooperation agreement with CERN European Organization for Nuclear Research (CERN), Geneva, Switzerland Imperial College London, London, United Kingdom
A Gomes Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
S Gomez Fernandez ICCUB, Universitat de Barcelona, Barcelona, Spain
F Goncalves Abrantes Department of Physics, University of Oxford, Oxford, United Kingdom
M Goncerz Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
G Gong Center for High Energy Physics, Tsinghua University, Beijing, China
J A Gooding Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
I V Gorelov Affiliated with an institute covered by a cooperation agreement with CERN
C Gotti INFN Sezione di Milano-Bicocca, Milano, Italy
J P Grabowski Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
L A Granado Cardoso European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Graugés ICCUB, Universitat de Barcelona, Barcelona, Spain
E Graverini Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
L Grazette Department of Physics, University of Warwick, Coventry, United Kingdom
G Graziani School of Physics and Astronomy, Monash University, Melbourne, Australia Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil Center for High Energy Physics, Tsinghua University, Beijing, China Institute Of High Energy Physics (IHEP), Beijing, China School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China University of Chinese Academy of Sciences, Beijing, China Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany School of Physics, University College Dublin, Dublin, Ireland INFN Sezione di Bari, Bari, Italy INFN Sezione di Bologna, Bologna, Italy INFN Sezione di Ferrara, Ferrara, Italy INFN Sezione di Firenze, Firenze, Italy INFN Laboratori Nazionali di Frascati, Frascati, Italy INFN Sezione di Genova, Genova, Italy INFN Sezione di Milano, Milano, Italy INFN Sezione di Milano-Bicocca, Milano, Italy INFN Sezione di Cagliari, Monserrato, Italy Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy INFN Sezione di Perugia, Perugia, Italy INFN Sezione di Pisa, Pisa, Italy INFN Sezione di Roma La Sapienza, Roma, Italy INFN Sezione di Roma Tor Vergata, Roma, Italy Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland National Center for Nuclear Research (NCBJ), Warsaw, Poland Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania Affiliated with an institute covered by a cooperation agreement with CERN DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain ICCUB, Universitat de Barcelona, Barcelona, Spain Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain European Organization for Nuclear Research (CERN), Geneva, Switzerland Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland Physik-Institut, Universität Zürich, Zürich, Switzerland NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine University of Birmingham, Birmingham, United Kingdom H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom Department of Physics, University of Warwick, Coventry, United Kingdom STFC Rutherford Appleton Laboratory, Didcot, United Kingdom School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom Imperial College London, London, United Kingdom Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom Department of Physics, University of Oxford, Oxford, United Kingdom Massachusetts Institute of Technology, Cambridge, Massachusetts, USA University of Cincinnati, Cincinnati, Ohio, USA University of Maryland, College Park, Maryland, USA Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA Syracuse University, Syracuse, New York, USA Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil) School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China) Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China) School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France) Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany) Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland) Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland) Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom) University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA) Departement de Physique Nucleaire (SPhN), Gif-Sur-Yvette, France
A T Grecu Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
L M Greeven Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
N A Grieser University of Cincinnati, Cincinnati, Ohio, USA
L Grillo School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
S Gromov Affiliated with an institute covered by a cooperation agreement with CERN
C Gu Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
M Guarise INFN Sezione di Ferrara, Ferrara, Italy
M Guittiere Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
V Guliaeva Affiliated with an institute covered by a cooperation agreement with CERN
P A Günther Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A-K Guseinov Affiliated with an institute covered by a cooperation agreement with CERN
E Gushchin Affiliated with an institute covered by a cooperation agreement with CERN
Y Guz School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China Affiliated with an institute covered by a cooperation agreement with CERN European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Gys European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Hadavizadeh School of Physics and Astronomy, Monash University, Melbourne, Australia
C Hadjivasiliou University of Maryland, College Park, Maryland, USA
G Haefeli Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
C Haen European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Haimberger European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Hajheidari European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Halewood-Leagas Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
M M Halvorsen European Organization for Nuclear Research (CERN), Geneva, Switzerland
P M Hamilton University of Maryland, College Park, Maryland, USA
J Hammerich Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
Q Han Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
X Han Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
S Hansmann-Menzemer Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
L Hao University of Chinese Academy of Sciences, Beijing, China
N Harnew Department of Physics, University of Oxford, Oxford, United Kingdom
T Harrison Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
M Hartmann Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
C Hasse European Organization for Nuclear Research (CERN), Geneva, Switzerland
J He University of Chinese Academy of Sciences, Beijing, China
K Heijhoff Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
F Hemmer European Organization for Nuclear Research (CERN), Geneva, Switzerland
C Henderson University of Cincinnati, Cincinnati, Ohio, USA
R D L Henderson School of Physics and Astronomy, Monash University, Melbourne, Australia Department of Physics, University of Warwick, Coventry, United Kingdom
A M Hennequin European Organization for Nuclear Research (CERN), Geneva, Switzerland
K Hennessy Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
L Henry Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J Herd Imperial College London, London, United Kingdom
J Heuel I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
A Hicheur Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
D Hill Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
S E Hollitt Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J Horswill Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
R Hou Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Hou Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
N Howarth Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
J Hu Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
J Hu Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
W Hu School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
X Hu Center for High Energy Physics, Tsinghua University, Beijing, China
W Huang University of Chinese Academy of Sciences, Beijing, China
W Hulsbergen Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
R J Hunter Department of Physics, University of Warwick, Coventry, United Kingdom
M Hushchyn Affiliated with an institute covered by a cooperation agreement with CERN
D Hutchcroft Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
M Idzik AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
D Ilin Affiliated with an institute covered by a cooperation agreement with CERN
P Ilten University of Cincinnati, Cincinnati, Ohio, USA
A Inglessi Affiliated with an institute covered by a cooperation agreement with CERN
A Iniukhin Affiliated with an institute covered by a cooperation agreement with CERN
A Ishteev Affiliated with an institute covered by a cooperation agreement with CERN
K Ivshin Affiliated with an institute covered by a cooperation agreement with CERN
R Jacobsson European Organization for Nuclear Research (CERN), Geneva, Switzerland
H Jage I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
S J Jaimes Elles Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
S Jakobsen European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Jans Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
B K Jashal Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
A Jawahery University of Maryland, College Park, Maryland, USA
V Jevtic Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
E Jiang University of Maryland, College Park, Maryland, USA
X Jiang Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
Y Jiang University of Chinese Academy of Sciences, Beijing, China
Y J Jiang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
M John Department of Physics, University of Oxford, Oxford, United Kingdom
D Johnson University of Birmingham, Birmingham, United Kingdom
C R Jones Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
T P Jones Department of Physics, University of Warwick, Coventry, United Kingdom
S Joshi National Center for Nuclear Research (NCBJ), Warsaw, Poland
B Jost European Organization for Nuclear Research (CERN), Geneva, Switzerland
N Jurik European Organization for Nuclear Research (CERN), Geneva, Switzerland
I Juszczak Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
D Kaminaris Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
S Kandybei NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine
Y Kang Center for High Energy Physics, Tsinghua University, Beijing, China
M Karacson European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Karpenkov Affiliated with an institute covered by a cooperation agreement with CERN
M Karpov Affiliated with an institute covered by a cooperation agreement with CERN
A M Kauniskangas Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J W Kautz University of Cincinnati, Cincinnati, Ohio, USA
F Keizer European Organization for Nuclear Research (CERN), Geneva, Switzerland
D M Keller Syracuse University, Syracuse, New York, USA
M Kenzie Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
T Ketel Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
B Khanji Syracuse University, Syracuse, New York, USA
A Kharisova Affiliated with an institute covered by a cooperation agreement with CERN
S Kholodenko INFN Sezione di Pisa, Pisa, Italy
G Khreich Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
T Kirn I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
V S Kirsebom Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
O Kitouni Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
S Klaver Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
N Kleijne INFN Sezione di Pisa, Pisa, Italy
K Klimaszewski National Center for Nuclear Research (NCBJ), Warsaw, Poland
M R Kmiec National Center for Nuclear Research (NCBJ), Warsaw, Poland
S Koliiev Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
L Kolk Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
A Konoplyannikov Affiliated with an institute covered by a cooperation agreement with CERN
P Kopciewicz AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland European Organization for Nuclear Research (CERN), Geneva, Switzerland
P Koppenburg Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
M Korolev Affiliated with an institute covered by a cooperation agreement with CERN
I Kostiuk Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
O Kot Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
S Kotriakhova School of Physics and Astronomy, Monash University, Melbourne, Australia Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil Center for High Energy Physics, Tsinghua University, Beijing, China Institute Of High Energy Physics (IHEP), Beijing, China School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China University of Chinese Academy of Sciences, Beijing, China Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany School of Physics, University College Dublin, Dublin, Ireland INFN Sezione di Bari, Bari, Italy INFN Sezione di Bologna, Bologna, Italy INFN Sezione di Ferrara, Ferrara, Italy INFN Sezione di Firenze, Firenze, Italy INFN Laboratori Nazionali di Frascati, Frascati, Italy INFN Sezione di Genova, Genova, Italy INFN Sezione di Milano, Milano, Italy INFN Sezione di Milano-Bicocca, Milano, Italy INFN Sezione di Cagliari, Monserrato, Italy Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy INFN Sezione di Perugia, Perugia, Italy INFN Sezione di Pisa, Pisa, Italy INFN Sezione di Roma La Sapienza, Roma, Italy INFN Sezione di Roma Tor Vergata, Roma, Italy Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland National Center for Nuclear Research (NCBJ), Warsaw, Poland Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania Affiliated with an institute covered by a cooperation agreement with CERN DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain ICCUB, Universitat de Barcelona, Barcelona, Spain Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain European Organization for Nuclear Research (CERN), Geneva, Switzerland Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland Physik-Institut, Universität Zürich, Zürich, Switzerland NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine University of Birmingham, Birmingham, United Kingdom H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom Department of Physics, University of Warwick, Coventry, United Kingdom STFC Rutherford Appleton Laboratory, Didcot, United Kingdom School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom Imperial College London, London, United Kingdom Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom Department of Physics, University of Oxford, Oxford, United Kingdom Massachusetts Institute of Technology, Cambridge, Massachusetts, USA University of Cincinnati, Cincinnati, Ohio, USA University of Maryland, College Park, Maryland, USA Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA Syracuse University, Syracuse, New York, USA Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil) School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China) Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China) School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France) Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany) Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland) Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland) Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom) University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA) Departement de Physique Nucleaire (SPhN), Gif-Sur-Yvette, France
A Kozachuk Affiliated with an institute covered by a cooperation agreement with CERN
P Kravchenko Affiliated with an institute covered by a cooperation agreement with CERN
L Kravchuk Affiliated with an institute covered by a cooperation agreement with CERN
M Kreps Department of Physics, University of Warwick, Coventry, United Kingdom
S Kretzschmar I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
P Krokovny Affiliated with an institute covered by a cooperation agreement with CERN
W Krupa Syracuse University, Syracuse, New York, USA
W Krzemien National Center for Nuclear Research (NCBJ), Warsaw, Poland
J Kubat Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
S Kubis Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
W Kucewicz Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
M Kucharczyk Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
V Kudryavtsev Affiliated with an institute covered by a cooperation agreement with CERN
E Kulikova Affiliated with an institute covered by a cooperation agreement with CERN
A Kupsc Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
B K Kutsenko Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
D Lacarrere European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Lai INFN Sezione di Cagliari, Monserrato, Italy
A Lampis INFN Sezione di Cagliari, Monserrato, Italy
D Lancierini Physik-Institut, Universität Zürich, Zürich, Switzerland
C Landesa Gomez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
J J Lane School of Physics and Astronomy, Monash University, Melbourne, Australia
R Lane H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
C Langenbruch Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
J Langer Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
O Lantwin Affiliated with an institute covered by a cooperation agreement with CERN
T Latham Department of Physics, University of Warwick, Coventry, United Kingdom
F Lazzari INFN Sezione di Pisa, Pisa, Italy
C Lazzeroni University of Birmingham, Birmingham, United Kingdom
R Le Gac Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
S H Lee University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
R Lefèvre Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
A Leflat Affiliated with an institute covered by a cooperation agreement with CERN
S Legotin Affiliated with an institute covered by a cooperation agreement with CERN
M Lehuraux Department of Physics, University of Warwick, Coventry, United Kingdom
O Leroy Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
T Lesiak Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
B Leverington Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Li Center for High Energy Physics, Tsinghua University, Beijing, China
H Li Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
K Li Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
L Li Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
P Li European Organization for Nuclear Research (CERN), Geneva, Switzerland
P-R Li Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
S Li Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
T Li Institute Of High Energy Physics (IHEP), Beijing, China
T Li Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
Y Li Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Li Institute Of High Energy Physics (IHEP), Beijing, China
Z Li Syracuse University, Syracuse, New York, USA
Z Lian Center for High Energy Physics, Tsinghua University, Beijing, China
X Liang Syracuse University, Syracuse, New York, USA
C Lin University of Chinese Academy of Sciences, Beijing, China
T Lin STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
R Lindner European Organization for Nuclear Research (CERN), Geneva, Switzerland
V Lisovskyi Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
R Litvinov INFN Sezione di Cagliari, Monserrato, Italy
G Liu Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
H Liu University of Chinese Academy of Sciences, Beijing, China
K Liu Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
Q Liu University of Chinese Academy of Sciences, Beijing, China
S Liu Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
Y Liu School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
Y Liu Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
Y L Liu Imperial College London, London, United Kingdom
A Lobo Salvia ICCUB, Universitat de Barcelona, Barcelona, Spain
A Loi INFN Sezione di Cagliari, Monserrato, Italy
J Lomba Castro Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
T Long Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
J H Lopes Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
A Lopez Huertas ICCUB, Universitat de Barcelona, Barcelona, Spain
S López Soliño Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G H Lovell Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
C Lucarelli INFN Sezione di Firenze, Firenze, Italy
D Lucchesi Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
S Luchuk Affiliated with an institute covered by a cooperation agreement with CERN
M Lucio Martinez Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
V Lukashenko Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
Y Luo Center for High Energy Physics, Tsinghua University, Beijing, China
A Lupato Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
E Luppi INFN Sezione di Ferrara, Ferrara, Italy
K Lynch School of Physics, University College Dublin, Dublin, Ireland
X-R Lyu University of Chinese Academy of Sciences, Beijing, China
G M Ma Center for High Energy Physics, Tsinghua University, Beijing, China
R Ma University of Chinese Academy of Sciences, Beijing, China
S Maccolini Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
F Machefert Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
F Maciuc Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
I Mackay Department of Physics, University of Oxford, Oxford, United Kingdom
L R Madhan Mohan Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
M M Madurai University of Birmingham, Birmingham, United Kingdom
A Maevskiy Affiliated with an institute covered by a cooperation agreement with CERN
D Magdalinski Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
D Maisuzenko Affiliated with an institute covered by a cooperation agreement with CERN
M W Majewski AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
J J Malczewski Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
S Malde Department of Physics, University of Oxford, Oxford, United Kingdom
B Malecki Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland European Organization for Nuclear Research (CERN), Geneva, Switzerland
L Malentacca European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Malinin Affiliated with an institute covered by a cooperation agreement with CERN
T Maltsev Affiliated with an institute covered by a cooperation agreement with CERN
G Manca INFN Sezione di Cagliari, Monserrato, Italy
G Mancinelli Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
C Mancuso Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France INFN Sezione di Milano, Milano, Italy
R Manera Escalero ICCUB, Universitat de Barcelona, Barcelona, Spain
D Manuzzi INFN Sezione di Bologna, Bologna, Italy
D Marangotto INFN Sezione di Milano, Milano, Italy
J F Marchand Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
R Marchevski Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
U Marconi INFN Sezione di Bologna, Bologna, Italy
S Mariani European Organization for Nuclear Research (CERN), Geneva, Switzerland
C Marin Benito ICCUB, Universitat de Barcelona, Barcelona, Spain European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Marks Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A M Marshall H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
P J Marshall Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
G Martelli INFN Sezione di Perugia, Perugia, Italy
G Martellotti INFN Sezione di Roma La Sapienza, Roma, Italy
L Martinazzoli European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Martinelli INFN Sezione di Milano-Bicocca, Milano, Italy
D Martinez Santos Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
F Martinez Vidal Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
A Massafferri Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
M Materok I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
R Matev European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Mathad Physik-Institut, Universität Zürich, Zürich, Switzerland
V Matiunin Affiliated with an institute covered by a cooperation agreement with CERN
C Matteuzzi Syracuse University, Syracuse, New York, USA
K R Mattioli Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
A Mauri Imperial College London, London, United Kingdom
E Maurice Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
J Mauricio ICCUB, Universitat de Barcelona, Barcelona, Spain
P Mayencourt Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Mazurek European Organization for Nuclear Research (CERN), Geneva, Switzerland
M McCann Imperial College London, London, United Kingdom
L Mcconnell School of Physics, University College Dublin, Dublin, Ireland
T H McGrath Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
N T McHugh School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A McNab Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
R McNulty School of Physics, University College Dublin, Dublin, Ireland
B Meadows University of Cincinnati, Cincinnati, Ohio, USA
G Meier Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D Melnychuk National Center for Nuclear Research (NCBJ), Warsaw, Poland
M Merk Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
A Merli INFN Sezione di Milano, Milano, Italy
L Meyer Garcia Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
D Miao Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
H Miao University of Chinese Academy of Sciences, Beijing, China
M Mikhasenko Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
D A Milanes Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
A Minotti INFN Sezione di Milano-Bicocca, Milano, Italy
E Minucci Syracuse University, Syracuse, New York, USA
T Miralles Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
S E Mitchell School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
B Mitreska Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D S Mitzel Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
A Modak STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
A Mödden Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
R A Mohammed Department of Physics, University of Oxford, Oxford, United Kingdom
R D Moise I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
S Mokhnenko Affiliated with an institute covered by a cooperation agreement with CERN
T Mombächer European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Monk School of Physics and Astronomy, Monash University, Melbourne, Australia Department of Physics, University of Warwick, Coventry, United Kingdom
I A Monroy Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
S Monteil Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
A Morcillo Gomez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G Morello INFN Laboratori Nazionali di Frascati, Frascati, Italy
M J Morello INFN Sezione di Pisa, Pisa, Italy
M P Morgenthaler Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
J Moron AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
A B Morris European Organization for Nuclear Research (CERN), Geneva, Switzerland
A G Morris Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
R Mountain Syracuse University, Syracuse, New York, USA
H Mu Center for High Energy Physics, Tsinghua University, Beijing, China
Z M Mu School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
E Muhammad Department of Physics, University of Warwick, Coventry, United Kingdom
F Muheim School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Mulder Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
K Müller Physik-Institut, Universität Zürich, Zürich, Switzerland
F Mũnoz-Rojas Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica
R Murta Imperial College London, London, United Kingdom
P Naik Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
T Nakada Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
R Nandakumar STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
T Nanut European Organization for Nuclear Research (CERN), Geneva, Switzerland
I Nasteva Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
M Needham School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
N Neri INFN Sezione di Milano, Milano, Italy
S Neubert Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
N Neufeld European Organization for Nuclear Research (CERN), Geneva, Switzerland
P Neustroev Affiliated with an institute covered by a cooperation agreement with CERN
R Newcombe Imperial College London, London, United Kingdom
J Nicolini Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D Nicotra Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
E M Niel Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
N Nikitin Affiliated with an institute covered by a cooperation agreement with CERN
P Nogga Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
N S Nolte Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
C Normand Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France INFN Sezione di Cagliari, Monserrato, Italy
J Novoa Fernandez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G Nowak University of Cincinnati, Cincinnati, Ohio, USA
C Nunez University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
H N Nur School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A Oblakowska-Mucha AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
V Obraztsov Affiliated with an institute covered by a cooperation agreement with CERN
T Oeser I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
S Okamura INFN Sezione di Ferrara, Ferrara, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
R Oldeman INFN Sezione di Cagliari, Monserrato, Italy
F Oliva School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Olocco Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
C J G Onderwater Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
R H O'Neil School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
J M Otalora Goicochea Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
T Ovsiannikova Affiliated with an institute covered by a cooperation agreement with CERN
P Owen Physik-Institut, Universität Zürich, Zürich, Switzerland
A Oyanguren Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
O Ozcelik School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
K O Padeken Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
B Pagare Department of Physics, University of Warwick, Coventry, United Kingdom
P R Pais Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
T Pajero Department of Physics, University of Oxford, Oxford, United Kingdom
A Palano INFN Sezione di Bari, Bari, Italy
M Palutan INFN Laboratori Nazionali di Frascati, Frascati, Italy
G Panshin Affiliated with an institute covered by a cooperation agreement with CERN
L Paolucci Department of Physics, University of Warwick, Coventry, United Kingdom
A Papanestis STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
M Pappagallo INFN Sezione di Bari, Bari, Italy
L L Pappalardo INFN Sezione di Ferrara, Ferrara, Italy
C Pappenheimer University of Cincinnati, Cincinnati, Ohio, USA
C Parkes Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
B Passalacqua INFN Sezione di Ferrara, Ferrara, Italy
G Passaleva INFN Sezione di Firenze, Firenze, Italy
D Passaro INFN Sezione di Pisa, Pisa, Italy
A Pastore INFN Sezione di Bari, Bari, Italy
M Patel Imperial College London, London, United Kingdom
J Patoc Department of Physics, University of Oxford, Oxford, United Kingdom
C Patrignani INFN Sezione di Bologna, Bologna, Italy
C J Pawley Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
A Pellegrino Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
M Pepe Altarelli INFN Laboratori Nazionali di Frascati, Frascati, Italy
S Perazzini INFN Sezione di Bologna, Bologna, Italy
D Pereima Affiliated with an institute covered by a cooperation agreement with CERN
A Pereiro Castro Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
P Perret Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
A Perro European Organization for Nuclear Research (CERN), Geneva, Switzerland
K Petridis H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
A Petrolini INFN Sezione di Genova, Genova, Italy
S Petrucci School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
H Pham Syracuse University, Syracuse, New York, USA
L Pica INFN Sezione di Pisa, Pisa, Italy
M Piccini INFN Sezione di Perugia, Perugia, Italy
B Pietrzyk Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
G Pietrzyk Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
D Pinci INFN Sezione di Roma La Sapienza, Roma, Italy
F Pisani European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Pizzichemi INFN Sezione di Milano-Bicocca, Milano, Italy
V Placinta Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
M Plo Casasus Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
F Polci LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Poli Lener INFN Laboratori Nazionali di Frascati, Frascati, Italy
A Poluektov Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
N Polukhina Affiliated with an institute covered by a cooperation agreement with CERN
I Polyakov European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Polycarpo Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
S Ponce European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Popov University of Chinese Academy of Sciences, Beijing, China
S Poslavskii Affiliated with an institute covered by a cooperation agreement with CERN
K Prasanth Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
C Prouve Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
V Pugatch Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
V Puill Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
G Punzi INFN Sezione di Pisa, Pisa, Italy
H R Qi Center for High Energy Physics, Tsinghua University, Beijing, China
W Qian University of Chinese Academy of Sciences, Beijing, China
N Qin Center for High Energy Physics, Tsinghua University, Beijing, China
S Qu Center for High Energy Physics, Tsinghua University, Beijing, China
R Quagliani Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
R I Rabadan Trejo Department of Physics, University of Warwick, Coventry, United Kingdom
B Rachwal AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
J H Rademacker H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
M Rama INFN Sezione di Pisa, Pisa, Italy
M Ramírez García University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
M Ramos Pernas Department of Physics, University of Warwick, Coventry, United Kingdom
M S Rangel Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
F Ratnikov Affiliated with an institute covered by a cooperation agreement with CERN
G Raven Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
M Rebollo De Miguel Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
F Redi European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Reich H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
F Reiss Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
Z Ren University of Chinese Academy of Sciences, Beijing, China
P K Resmi Department of Physics, University of Oxford, Oxford, United Kingdom
R Ribatti INFN Sezione di Pisa, Pisa, Italy
G R Ricart Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France Departement de Physique Nucleaire (SPhN), Gif-Sur-Yvette, France
D Riccardi INFN Sezione di Pisa, Pisa, Italy
S Ricciardi STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
K Richardson Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
M Richardson-Slipper School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
K Rinnert Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
P Robbe Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
G Robertson School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
E Rodrigues European Organization for Nuclear Research (CERN), Geneva, Switzerland Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
E Rodriguez Fernandez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
J A Rodriguez Lopez Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
E Rodriguez Rodriguez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A Rogovskiy STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
D L Rolf European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Rollings Department of Physics, University of Oxford, Oxford, United Kingdom
P Roloff European Organization for Nuclear Research (CERN), Geneva, Switzerland
V Romanovskiy Affiliated with an institute covered by a cooperation agreement with CERN
M Romero Lamas Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A Romero Vidal Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G Romolini INFN Sezione di Ferrara, Ferrara, Italy
F Ronchetti Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Rotondo INFN Laboratori Nazionali di Frascati, Frascati, Italy
S R Roy Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M S Rudolph Syracuse University, Syracuse, New York, USA
T Ruf European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Ruiz Diaz Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
R A Ruiz Fernandez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
J Ruiz Vidal Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
A Ryzhikov Affiliated with an institute covered by a cooperation agreement with CERN
J Ryzka AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
J J Saborido Silva Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
R Sadek Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
N Sagidova Affiliated with an institute covered by a cooperation agreement with CERN
N Sahoo University of Birmingham, Birmingham, United Kingdom
B Saitta INFN Sezione di Cagliari, Monserrato, Italy
M Salomoni INFN Sezione di Milano-Bicocca, Milano, Italy
C Sanchez Gras Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
I Sanderswood Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
R Santacesaria INFN Sezione di Roma La Sapienza, Roma, Italy
C Santamarina Rios Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
M Santimaria INFN Laboratori Nazionali di Frascati, Frascati, Italy
L Santoro Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
E Santovetti INFN Sezione di Roma Tor Vergata, Roma, Italy
A Saputi INFN Sezione di Ferrara, Ferrara, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Saranin Affiliated with an institute covered by a cooperation agreement with CERN
G Sarpis School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Sarpis Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
A Sarti INFN Sezione di Roma La Sapienza, Roma, Italy
C Satriano INFN Sezione di Roma La Sapienza, Roma, Italy
A Satta INFN Sezione di Roma Tor Vergata, Roma, Italy
M Saur School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
D Savrina Affiliated with an institute covered by a cooperation agreement with CERN
H Sazak Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
L G Scantlebury Smead Department of Physics, University of Oxford, Oxford, United Kingdom
A Scarabotto LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
S Schael I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
S Scherl Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
A M Schertz Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland)
M Schiller School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
H Schindler European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Schmelling Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
B Schmidt European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Schmitt I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
H Schmitz Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
O Schneider Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
A Schopper European Organization for Nuclear Research (CERN), Geneva, Switzerland
N Schulte Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
S Schulte Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M H Schune Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
R Schwemmer European Organization for Nuclear Research (CERN), Geneva, Switzerland
G Schwering I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
B Sciascia INFN Laboratori Nazionali di Frascati, Frascati, Italy
A Sciuccati European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Sellam Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A Semennikov Affiliated with an institute covered by a cooperation agreement with CERN
M Senghi Soares Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
A Sergi INFN Sezione di Genova, Genova, Italy
N Serra European Organization for Nuclear Research (CERN), Geneva, Switzerland Physik-Institut, Universität Zürich, Zürich, Switzerland
L Sestini Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
A Seuthe Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
Y Shang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
D M Shangase University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
M Shapkin Affiliated with an institute covered by a cooperation agreement with CERN
I Shchemerov Affiliated with an institute covered by a cooperation agreement with CERN
L Shchutska Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
T Shears Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
L Shekhtman Affiliated with an institute covered by a cooperation agreement with CERN
Z Shen School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
S Sheng Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
V Shevchenko Affiliated with an institute covered by a cooperation agreement with CERN
B Shi University of Chinese Academy of Sciences, Beijing, China
E B Shields INFN Sezione di Milano-Bicocca, Milano, Italy
Y Shimizu Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
E Shmanin Affiliated with an institute covered by a cooperation agreement with CERN
R Shorkin Affiliated with an institute covered by a cooperation agreement with CERN
J D Shupperd Syracuse University, Syracuse, New York, USA
R Silva Coutinho Syracuse University, Syracuse, New York, USA
G Simi Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
S Simone INFN Sezione di Bari, Bari, Italy
N Skidmore Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
R Skuza Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
T Skwarnicki Syracuse University, Syracuse, New York, USA
M W Slater University of Birmingham, Birmingham, United Kingdom
J C Smallwood Department of Physics, University of Oxford, Oxford, United Kingdom
E Smith Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
K Smith Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
M Smith Imperial College London, London, United Kingdom
A Snoch Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
L Soares Lavra School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M D Sokoloff University of Cincinnati, Cincinnati, Ohio, USA
F J P Soler School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A Solomin Affiliated with an institute covered by a cooperation agreement with CERN H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
A Solovev Affiliated with an institute covered by a cooperation agreement with CERN
I Solovyev Affiliated with an institute covered by a cooperation agreement with CERN
R Song School of Physics and Astronomy, Monash University, Melbourne, Australia
Y Song Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
Y Song Center for High Energy Physics, Tsinghua University, Beijing, China
Y S Song School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
F L Souza De Almeida Syracuse University, Syracuse, New York, USA
B Souza De Paula Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
E Spadaro Norella INFN Sezione di Milano, Milano, Italy
E Spedicato INFN Sezione di Bologna, Bologna, Italy
J G Speer Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
E Spiridenkov Affiliated with an institute covered by a cooperation agreement with CERN
P Spradlin School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
V Sriskaran European Organization for Nuclear Research (CERN), Geneva, Switzerland
F Stagni European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Stahl European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Stahl European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Stanislaus Department of Physics, University of Oxford, Oxford, United Kingdom
E N Stein European Organization for Nuclear Research (CERN), Geneva, Switzerland
O Steinkamp Physik-Institut, Universität Zürich, Zürich, Switzerland
O Stenyakin Affiliated with an institute covered by a cooperation agreement with CERN
H Stevens Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D Strekalina Affiliated with an institute covered by a cooperation agreement with CERN
Y Su University of Chinese Academy of Sciences, Beijing, China
F Suljik Department of Physics, University of Oxford, Oxford, United Kingdom
J Sun INFN Sezione di Cagliari, Monserrato, Italy
L Sun School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
Y Sun University of Maryland, College Park, Maryland, USA
P N Swallow University of Birmingham, Birmingham, United Kingdom
K Swientek AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
F Swystun Department of Physics, University of Warwick, Coventry, United Kingdom
A Szabelski National Center for Nuclear Research (NCBJ), Warsaw, Poland
T Szumlak AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
M Szymanski European Organization for Nuclear Research (CERN), Geneva, Switzerland
Y Tan Center for High Energy Physics, Tsinghua University, Beijing, China
S Taneja Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M D Tat Department of Physics, University of Oxford, Oxford, United Kingdom
A Terentev Physik-Institut, Universität Zürich, Zürich, Switzerland
F Terzuoli INFN Sezione di Pisa, Pisa, Italy
F Teubert European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Thomas European Organization for Nuclear Research (CERN), Geneva, Switzerland
D J D Thompson University of Birmingham, Birmingham, United Kingdom
H Tilquin Imperial College London, London, United Kingdom
V Tisserand Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
S T'Jampens Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
M Tobin Institute Of High Energy Physics (IHEP), Beijing, China
L Tomassetti INFN Sezione di Ferrara, Ferrara, Italy
G Tonani INFN Sezione di Milano, Milano, Italy
X Tong School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
D Torres Machado Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
L Toscano Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D Y Tou Center for High Energy Physics, Tsinghua University, Beijing, China
C Trippl DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
G Tuci Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
N Tuning Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
L H Uecker Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Ukleja AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
D J Unverzagt Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
E Ursov Affiliated with an institute covered by a cooperation agreement with CERN
A Usachov Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
A Ustyuzhanin Affiliated with an institute covered by a cooperation agreement with CERN
U Uwer Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
V Vagnoni INFN Sezione di Bologna, Bologna, Italy
A Valassi European Organization for Nuclear Research (CERN), Geneva, Switzerland
G Valenti INFN Sezione di Bologna, Bologna, Italy
N Valls Canudas DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
H Van Hecke Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
E van Herwijnen Imperial College London, London, United Kingdom
C B Van Hulse Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
R Van Laak Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M van Veghel Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
R Vazquez Gomez ICCUB, Universitat de Barcelona, Barcelona, Spain
P Vazquez Regueiro Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
C Vázquez Sierra Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
S Vecchi INFN Sezione di Ferrara, Ferrara, Italy
J J Velthuis H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
M Veltri INFN Sezione di Firenze, Firenze, Italy
A Venkateswaran Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Vesterinen Department of Physics, University of Warwick, Coventry, United Kingdom
D Vieira University of Cincinnati, Cincinnati, Ohio, USA
M Vieites Diaz European Organization for Nuclear Research (CERN), Geneva, Switzerland
X Vilasis-Cardona DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
E Vilella Figueras Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
A Villa INFN Sezione di Bologna, Bologna, Italy
P Vincent LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
F C Volle Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
D Vom Bruch Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
V Vorobyev Affiliated with an institute covered by a cooperation agreement with CERN
N Voropaev Affiliated with an institute covered by a cooperation agreement with CERN
K Vos Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
G Vouters Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
C Vrahas School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
J Walsh INFN Sezione di Pisa, Pisa, Italy
E J Walton School of Physics and Astronomy, Monash University, Melbourne, Australia
G Wan School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
C Wang Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
G Wang Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
J Wang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
J Wang Institute Of High Energy Physics (IHEP), Beijing, China
J Wang Center for High Energy Physics, Tsinghua University, Beijing, China
J Wang School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
M Wang INFN Sezione di Milano, Milano, Italy
N W Wang University of Chinese Academy of Sciences, Beijing, China
R Wang H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
X Wang Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
X W Wang Imperial College London, London, United Kingdom
Y Wang Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Z Wang Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
Z Wang Center for High Energy Physics, Tsinghua University, Beijing, China
Z Wang University of Chinese Academy of Sciences, Beijing, China
J A Ward School of Physics and Astronomy, Monash University, Melbourne, Australia Department of Physics, University of Warwick, Coventry, United Kingdom
N K Watson University of Birmingham, Birmingham, United Kingdom
D Websdale Imperial College London, London, United Kingdom
Y Wei School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
B D C Westhenry H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
D J White Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M Whitehead School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A R Wiederhold Department of Physics, University of Warwick, Coventry, United Kingdom
D Wiedner Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
G Wilkinson Department of Physics, University of Oxford, Oxford, United Kingdom
M K Wilkinson University of Cincinnati, Cincinnati, Ohio, USA
M Williams Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
M R J Williams School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
R Williams Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
F F Wilson STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
W Wislicki National Center for Nuclear Research (NCBJ), Warsaw, Poland
M Witek Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
L Witola Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
C P Wong Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
G Wormser Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
S A Wotton Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
H Wu Syracuse University, Syracuse, New York, USA
J Wu Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Wu School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
K Wyllie European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Xian Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
Z Xiang Institute Of High Energy Physics (IHEP), Beijing, China
Y Xie Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
A Xu INFN Sezione di Pisa, Pisa, Italy
J Xu University of Chinese Academy of Sciences, Beijing, China
L Xu Center for High Energy Physics, Tsinghua University, Beijing, China
L Xu Center for High Energy Physics, Tsinghua University, Beijing, China
M Xu Department of Physics, University of Warwick, Coventry, United Kingdom
Z Xu Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
Z Xu University of Chinese Academy of Sciences, Beijing, China
Z Xu Institute Of High Energy Physics (IHEP), Beijing, China
D Yang Center for High Energy Physics, Tsinghua University, Beijing, China
S Yang University of Chinese Academy of Sciences, Beijing, China
X Yang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Y Yang INFN Sezione di Genova, Genova, Italy
Z Yang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Z Yang University of Maryland, College Park, Maryland, USA
V Yeroshenko Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
H Yeung Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
H Yin Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
C Y Yu School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
J Yu School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
X Yuan Institute Of High Energy Physics (IHEP), Beijing, China
E Zaffaroni Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Zavertyaev Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
M Zdybal Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
M Zeng Center for High Energy Physics, Tsinghua University, Beijing, China
C Zhang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
D Zhang Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
J Zhang University of Chinese Academy of Sciences, Beijing, China
L Zhang Center for High Energy Physics, Tsinghua University, Beijing, China
S Zhang School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
S Zhang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Y Zhang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Y Zhang Department of Physics, University of Oxford, Oxford, United Kingdom
Y Z Zhang Center for High Energy Physics, Tsinghua University, Beijing, China
Y Zhao Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Zharkova Affiliated with an institute covered by a cooperation agreement with CERN
A Zhelezov Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
X Z Zheng Center for High Energy Physics, Tsinghua University, Beijing, China
Y Zheng University of Chinese Academy of Sciences, Beijing, China
T Zhou School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
X Zhou Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Zhou University of Chinese Academy of Sciences, Beijing, China
V Zhovkovska Department of Physics, University of Warwick, Coventry, United Kingdom
L Z Zhu University of Chinese Academy of Sciences, Beijing, China
X Zhu Center for High Energy Physics, Tsinghua University, Beijing, China
X Zhu Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Z Zhu University of Chinese Academy of Sciences, Beijing, China
V Zhukov I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany Affiliated with an institute covered by a cooperation agreement with CERN
J Zhuo Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
Q Zou Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
D Zuliani Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
G Zunica Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom

Collapse

B cell memory: from generation to reactivation: a multipronged defense wall against pathogens

Development of B cell memory is a conundrum that scientists are still exploring. Studies have been conducted in vitro and using advanced animal models to elucidate the mechanism underlying the generation of memory B cells (MBCs), the precise roles of MBCs against pathogens, and their protective functions against repeated infections throughout life. Lifelong immunity against invading diseases is mainly the result of overcoming a single infection. This protection is largely mediated by the two main components of B cell memory-MBCs and long-lived plasma cells (PCs). The chemical and cellular mechanisms that encourage fat selection for MBCs or long-lived PCs are an area of active research. Despite the fact that nearly all available vaccinations rely on the capacity to elicit B-cell memory, we have yet to develop successful vaccines that can induce broad-scale protective MBCs against some of the deadliest diseases, including malaria and AIDS. A deeper understanding of the specific cellular and molecular pathways that govern the generation, function, and reactivation of MBCs is critical for overcoming the challenges associated with vaccine development. Here, we reviewed literature on the development of MBCs and their reactivation, interaction with other cell types, strategies against invading pathogens, and function throughout life and discussed the recent advances regarding the key signals and transcription factors which regulate B cell memory and their relevance to the quest for vaccine development.

Comparison of the Biomechanical Properties between Healthy and Whole Human and Porcine Stomachs

Gastric cancer poses a societal and economic burden, prompting an exploration into the development of materials suitable for gastric reconstruction. However, there is a dearth of studies on the mechanical properties of porcine and human stomachs. Therefore, this study was conducted to elucidate their mechanical properties, focusing on interspecies correlations. Stress relaxation and tensile tests assessed the hyperelastic and viscoelastic characteristics of porcine and human stomachs. The thickness, stress-strain curve, elastic modulus, and stress relaxation were assessed. Porcine stomachs were significantly thicker than human stomachs. The stiffness contrast between porcine and human stomachs was evident. Porcine stomachs demonstrated varying elastic modulus values, with the highest in the longitudinal mucosa layer of the corpus and the lowest in the longitudinal intact layer of the fundus. In human stomachs, the elastic modulus of the longitudinal muscular layer of the antrum was the highest, whereas that of the circumferential muscularis layer of the corpus was the lowest. The degree of stress relaxation was higher in human stomachs than in porcine stomachs. This study comprehensively elucidated the differences between porcine and human stomachs attributable to variations across different regions and tissue layers, providing essential biomechanical support for subsequent studies in this field.

Observation of Cabibbo-Suppressed Two-Body Hadronic Decays and Precision Mass Measurement of the Ω_{c}^{0} Baryon

The first observation of the singly Cabibbo-suppressed Ω_{c}^{0}→Ω^{-}K^{+} and Ω_{c}^{0}→Ξ^{-}π^{+} decays is reported, using proton-proton collision data at a center-of-mass energy of 13 TeV, corresponding to an integrated luminosity of 5.4  fb^{-1}, collected with the LHCb detector between 2016 and 2018. The branching fraction ratios are measured to be B(Ω_{c}^{0}→Ω^{-}K^{+})/B(Ω_{c}^{0}→Ω^{-}π^{+})=[6.08±0.51(stat)±0.40(syst)]%,B(Ω_{c}^{0}→Ξ^{-}π^{+})/B(Ω_{c}^{0}→Ω^{-}π^{+})=[15.81±0.87(stat)±0.44(syst)±0.16(ext)]%. In addition, using the Ω_{c}^{0}→Ω^{-}π^{+} decay channel, the Ω_{c}^{0} baryon mass is measured to be M(Ω_{c}^{0})=2695.28±0.07(stat)±0.27(syst)±0.30(ext)  MeV, improving the precision of the previous world average by a factor of 4.

Enhanced Production of Λ_{b}^{0} Baryons in High-Multiplicity pp Collisions at sqrt[s]=13 TeV

The production rate of Λ_{b}^{0} baryons relative to B^{0} mesons in pp collisions at a center-of-mass energy sqrt[s]=13  TeV is measured by the LHCb experiment. The ratio of Λ_{b}^{0} to B^{0} production cross sections shows a significant dependence on both the transverse momentum and the measured charged-particle multiplicity. At low multiplicity, the ratio measured at LHCb is consistent with the value measured in e^{+}e^{-} collisions, and increases by a factor of ∼2 with increasing multiplicity. At relatively low transverse momentum, the ratio of Λ_{b}^{0} to B^{0} cross sections is higher than what is measured in e^{+}e^{-} collisions, but converges with the e^{+}e^{-} ratio as the momentum increases. These results imply that the evolution of heavy b quarks into final-state hadrons is influenced by the density of the hadronic environment produced in the collision. Comparisons with several models and implications for the mechanisms enforcing quark confinement are discussed.

Biomechanical evaluation on a new type of vertebral titanium porous mini-plate and mechanical comparison between cervical open-door laminoplasty and laminectomy: a finite element analysis

Objective: Compare the spine's stability after laminectomy (LN) and laminoplasty (LP) for two posterior surgeries. Simultaneously, design a new vertebral titanium porous mini plate (TPMP) to achieve firm fixation of the open-door vertebral LP fully. The objective is to enhance the fixation stability, effectively prevent the possibility of "re-closure," and may facilitate bone healing. Methods: TPMP was designed by incorporating a fusion body and porous structures, and a three-dimensional finite element cervical model of C2-T1 was constructed and validated. Load LN and LP finite element models, respectively, and analyze and simulate the detailed processes of the two surgeries. It was simultaneously implanting the TPMP into LP to evaluate its biomechanical properties. Results: We find that the range of motion (ROM) of C4-C5 after LN surgery was greater than that of LP implanted with different plates alone. Furthermore, flexion-extension, lateral bending, and axial rotation reflect this change. More noteworthy is that LN has a much larger ROM on C2-C3 in axial rotation. The ROM of LP implanted with two different plates is similar. There is almost no difference in facet joint stress in lateral bending. The facet joint stress of LN is smaller on C2-C3 and C4-C5, and larger more prominent on C5-C6 in the flexion-extension. Regarding intervertebral disc pressure (IDP), there is little difference between different surgeries except for the LN on C2-C3 in axial rotation. The plate displacement specificity does not significantly differ from LP with vertebral titanium mini-plate (TMP) and LP with TPMP after surgery. The stress of LP with TPMP is larger in C4-C5, C5-C6. Moreover, LP with TMP shows greater stress in the C3-C4 during flexion-extension and lateral bending. Conclusion: LP may have better postoperative stability when posterior approach surgery is used to treat CSM; at the same time, the new type of vertebral titanium mini-plate can achieve almost the same effect as the traditional titanium mini-plate after surgery for LP. In addition, it has specific potential due to the porous structure promoting bone fusion.

Improved Measurement of CP Violation Parameters in B_{s}^{0}→J/ψK^{+}K^{-} Decays in the Vicinity of the ϕ(1020) Resonance

The decay-time-dependent CP asymmetry in B_{s}^{0}→J/ψ(→μ^{+}μ^{-})K^{+}K^{-} decays is measured using proton-proton collision data, corresponding to an integrated luminosity of 6  fb^{-1}, collected with the LHCb detector at a center-of-mass energy of 13 TeV. Using a sample of approximately 349 000 B_{s}^{0} signal decays with an invariant K^{+}K^{-} mass in the vicinity of the ϕ(1020) resonance, the CP-violating phase ϕ_{s} is measured, along with the difference in decay widths of the light and heavy mass eigenstates of the B_{s}^{0}-B[over ¯]_{s}^{0} system, ΔΓ_{s}, and the difference of the average B_{s}^{0} and B^{0} meson decay widths, Γ_{s}-Γ_{d}. The values obtained are ϕ_{s}=-0.039±0.022±0.006  rad, ΔΓ_{s}=0.0845±0.0044±0.0024  ps^{-1}, and Γ_{s}-Γ_{d}=-0.0056_{-0.0015}^{+0.0013}±0.0014  ps^{-1}, where the first uncertainty is statistical and the second systematic. These are the most precise single measurements to date and are consistent with expectations based on the Standard Model and with the previous LHCb analyses of this decay. These results are combined with previous independent LHCb measurements. The phase ϕ_{s} is also measured independently for each polarization state of the K^{+}K^{-} system and shows no evidence for polarization dependence.

Genome-wide association study identifies multiple loci influencing duck serum biochemical indicators in the laying period

1. Laying performance is an important economic trait in poultry. The blood is essential in transporting nutrients to the yolk and albumen and is necessary for egg formation.2. This study calculated the phenotypic relationships of duck egg quality, egg production efficiency and 22 serum parameters in the egg-laying stage. Using a variety of methodologies, a genome-wide association study (GWAS) was carried out to uncover the genetic foundations of the 22 serum biochemical markers of laying ducks.3. Spearman correlation coefficients between the egg production (226-329 per day) and the serum parameters were all weak, being less than 0.3. This analysis was done on 22 serum parameters, with total protein (TP), total triglycerides (TG), calcium (Ca) and phosphorous (P) having the highest correlation coefficients (r = 0.56-0.88). The coefficients for blood markers, such as total cholesterol (CHOL), total bilirubin (TBIL), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) varied from 0.70-0.94.4. Based on single-marker single-trait genome-wide analyses by a mixed linear model program of EMMAX, nine candidate genes were associated with enzyme traits (AST/ALT aspartate transaminase/glutamic-pyruvic transaminase, creatine kinase) and 19 candidate genes were associated with metabolism and protein-related serum parameters (glucose, total bile acid, uric acid (UA), albumin (ALB).5. The mvLMM (multivariate linear mixed model) of GEMMA software was used to carry out multiple trait integrated GWAS. Two candidate genes were found in the TP-TG-CA-P analysis and seven candidate genes in the CHOL_LDL-C_HDL-C_TBIL study. There was a high genetic correlation between the two groups.

LINC01094 promotes human nasal epithelial cell epithelial-to-mesenchymal transition and pyroptosis via upregulating HMGB1

BACKGROUND

Excessive epithelial-to-mesenchymal transition (EMT) of nasal epithelial cells (NECs) play a prominent role in chronic rhinosinusitis with nasal polyps (CRSwNP) pathogenesis. Long intergenic non-coding RNA 01094 (LINC01094) was previously reported to be overexpressed in CRSwNP, while the regulatory mechanism by which LINC01094 regulates CRSwNP progression remains unclear. Our study aimed to investigate the role of LINC01094 in CRSwNP development.

METHODS

hNEC were isolated from tissues of controls and CRSwNP patients and stimulated with interleukin (IL)-13. 3-(4, 5-Dimethylthiazolyl2)-2, 5-diphenyltetrazolium bromide (MTT) assay was employed to analyze hNEC viability. Flow cytometry was employed to analyze pyroptosis. Immunofluorescence was employed to analyze Snail nuclear translocation. The interactions between LINC01094, fused in sarcoma (FUS) and high mobility group box-1 (HMGB1) were analyzed by RNA immunoprecipitation (RIP) and RNA pull-down assays.

RESULTS

LINC01094 and EMT-related proteins were markedly upregulated in nasal polyp tissues of CRSwNP. LINC01094 knockdown inhibited IL-13-induced hNEC EMT and pyroptosis. LINC01094 promoted HMGB1 expression in CRSwNP by binding with FUS. HMGB1 promoted Snail nuclear import in GSK-B phosphorylation-dependent manner.

CONCLUSION

LINC01094 facilitated hNEC EMT and pyroptosis in CRSwNP by activating the HMGB1/GSK-B Snail axis, which suggested that LINC01094 might serve as a biomarker and therapeutic target in CRSwNP.

Measurement of CP Violation in B^{0}→ψ(→ℓ^{+}ℓ^{-})K_{S}^{0}(→π^{+}π^{-}) Decays

A measurement of time-dependent CP violation in the decays of B^{0} and B[over ¯]^{0} mesons to the final states J/ψ(→μ^{+}μ^{-})K_{S}^{0}, ψ(2S)(→μ^{+}μ^{-})K_{S}^{0} and J/ψ(→e^{+}e^{-})K_{S}^{0} with K_{S}^{0}→π^{+}π^{-} is presented. The data correspond to an integrated luminosity of 6  fb^{-1} collected at a center-of-mass energy of sqrt[s]=13  TeV with the LHCb detector. The CP-violation parameters are measured to be S_{ψK_{S}^{0}}=0.717±0.013(stat)±0.008(syst) and C_{ψK_{S}^{0}}=0.008±0.012(stat)±0.003(syst). This measurement of S_{ψK_{S}^{0}} represents the most precise single measurement of the CKM angle β to date and is more precise than the current world average. In addition, measurements of the CP-violation parameters of the individual channels are reported and a combination with the LHCb Run 1 measurements is performed.

[Reappraisals of biological behaviors of PDGFRA mutant gastrointestinal stromal tumor]

Objective: To investigate the biological behavior spectrum of platelet-derived growth factor alpha receptor (PDGFRA)-mutant gastrointestinal stromal tumor (GIST), and to compare the clinical values of the Zhongshan method of benign and malignant evaluation with the modified National Institutes of Health (NIH) risk stratification. Methods: A total of 119 cases of GIST with PDGFRA mutation who underwent surgical resection at Zhongshan Hospital, Fudan University from 2009 to 2020 were collected. The clinicopathological data, follow-up records, and subsequent treatment were reviewed and analyzed statistically. Results: There were 79 males and 40 females. The patients ranged in age from 25 to 80 years, with a median age of 60 years. Among them, 115 patients were followed up for 1-154 months, and 13 patients progressed to disease. The 5-year disease-free survival (DFS) and overall survival (OS) were 90.1% and 94.1%, respectively. According to the modified NIH risk stratification, 8 cases, 32 cases, 38 cases, and 35 cases were very-low risk, low risk, intermediate risk, and high risk, and 5-year DFS were 100.0%, 95.6%, 94.3%, and 80.5%, respectively. There was no significant difference in prognosis among the non-high risk groups, only the difference between high risk and non-high risk groups was significant (P=0.029). However, the 5-year OS was 100.0%, 100.0%, 95.0% and 89.0%, and there was no difference (P=0.221). According to the benign and malignant evaluation Zhongshan method, 43 cases were non-malignant (37.4%), 56 cases were low-grade malignant (48.7%), 9 cases were moderately malignant (7.8%), and 7 cases were highly malignant (6.1%). The 5-year DFS were 100.0%, 91.7%, 77.8%, 38.1%, and the difference was significant (P<0.001). The 5-year OS were 100.0%, 97.5%, 77.8%, 66.7%, the difference was significant (P<0.001). Conclusions: GIST with PDGFRA gene mutation shows a broad range of biological behavior, ranging from benign to highly malignant. According to the Zhongshan method, non-malignant and low-grade malignant tumors are common, the prognosis after surgery is good, while the fewer medium-high malignant tumors showed poor prognosis after surgical resection. The overall biological behavior of this type of GIST is relatively inert, which is due to the low proportion of medium-high malignant GIST. The modified NIH risk stratification may not be effective in risk stratification for PDGFRA mutant GIST.

Lactate coordinated with exercise promoted the browning of inguinal white adipose tissue

Lactate, an important exercise metabolite, induces white adipose tissue browning by upregulated uncoupling protein 1 (UCP1) expression. However, the function of lactate during browning of inguinal white adipose tissue (iWAT) caused by exercise is unclear. Here, we considered lactate as an exercise supplement and investigated the effects of chronic pre-exercise lactate administration on energy metabolism and adipose tissue browning. C57B/L6 male mice (5 weeks of age) were divided into six groups. We evaluated the changes in blood lactate levels in each group of mice after the intervention. Energy expenditure was measured after the intervention immediately by indirect calorimetry. The marker protein levels and gene expressions were determined by western-blot and quantitative real-time PCR. HIIT significantly decreased adipose tissue weight while increased energy expenditure and the expression of UCP1 in iWAT; however, these regulations were inhibited in the DCA+HIIT group. Compared with the MICT and LAC groups, long-term lactate injection before MICT led to lower WAT weight to body weight ratios and higher energy expenditure in mice. Furthermore, the marker genes of browning in iWAT, such as Ucp1 and Pparγ, were significantly increased in the LAC+MICT group than in the other groups, and the expression of monocarboxylate transporter-1 (Mct1) mRNA was also significantly increased. Lactate was involved in exercise-mediated browning of iWAT, and its mechanism might be the increased of lactate transport through MCT1 or PPARγ upregulation induced by exercise. These findings suggest exogenous lactate may be a new exercise supplement to regulate metabolism.

Engineering Cardiac Tissue for Advanced Heart-On-A-Chip Platforms

Cardiovascular disease is a major cause of mortality worldwide, and current preclinical models including traditional animal models and 2D cell culture models have limitations in replicating human native heart physiology and response to drugs. Heart-on-a-chip (HoC) technology offers a promising solution by combining the advantages of cardiac tissue engineering and microfluidics to create in vitro 3D cardiac models, which can mimic key aspects of human microphysiological systems and provide controllable microenvironments. Herein, recent advances in HoC technologies are introduced, including engineered cardiac microtissue construction in vitro, microfluidic chip fabrication, microenvironmental stimulation, and real-time feedback systems. The development of cardiac tissue engineering methods is focused for 3D microtissue preparation, advanced strategies for HoC fabrication, and current applications of these platforms. Major challenges in HoC fabrication are discussed and the perspective on the potential for these platforms is provided to advance research and clinical applications.

Overlapping lockup lymphaticovenous anastomosis: A useful addition to supermicrosurgery

BACKGROUND

Lymphaticovenular anastomosis (LVA) is a minimally invasive surgical procedure used to treat lymphedema. This surgical procedure connects the superficial lymphatic vessels to nearby veins to establish lymphatic-venous pathways. One of the most common challenges encountered by lymphatic surgeons when performing LVA is a mismatch in the sizes of the veins and lymphatic vessels, with the effectiveness limited by technical constraints. We conducted a pilot study to evaluate the feasibility of an overlapping lockup anastomosis (OLA) LVA technique to address these problems.

METHODS

In this study, we present a novel OLA technique for LVA that addresses the challenges with conventional techniques. The OLA technique was used in 10 lymphedema patients between September 2022 and March 2023 to compare OLA and end-to-end anastomosis. The time required for anastomosis, method of anastomosis, patency rates, and lymphedema volume were evaluated in this study.

RESULTS

Of 123 LVAs, 44 were performed using the OLA technique in 10 patients, with indocyanine green lymphangiography revealing unobstructed drainage. A single case of slight fluid leakage occurred, which was resolved by reinforcing the sutures. The average anastomosis time for OLA and the end-to-end technique was 5.55 minutes and 12.1 minutes, respectively. The wounds of the patients healed without infection, and the subjective limb circumference decreased.

CONCLUSIONS

The OLA technique could serve as a valuable addition to the current LVA technique, especially for cases with a mismatch in the sizes of the lymphatic vessels and veins. This technique has the potential to promote the broader application of LVA in the treatment and prevention of lymphedema.

RBM3 Accelerates Wound Healing of Skin in Diabetes through ERK1/2 Signaling

BACKGROUND

With the increasing risk of infections and other serious complications, the underlying molecular mechanism of wound healing impairment in diabetes deserves attention. Cold shock proteins (CSPs), including CIRP and RBM3 are highly expressed in the skin; however, it is unknown whether CSPs are involved in the wound-healing impairment of diabetic skin.

OBJECTIVES

The objective of this study is to investigate the effects of RBM3 on skin wound healing in diabetes.

METHODS

In vitro experiments, western blot assay was used to test the levels of proteins in HaCaT cells treated with different concentrations of glucose. RBM3 was over-expressed in HaCaT cells using lentivirus particles. Cell viability was analyzed by Cell-Counting Kit-8 assay and colony formation assay. The migration of HaCaT cells at different concentrations of glucose was evaluated by wound healing assay. In vivo experiments, the mouse model of diabetes was established by intraperitoneal injection of streptozotocin. Four weeks later, the mice were anesthetized by intraperitoneal injection of pentobarbital sodium for skin tissue collection or wound healing experiments. RBM3 knockout mice were established by removing exons 2-6 using the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 technique and then used in skin wound healing experiments with or without diabetic stress.

RESULTS

In this study, the expression of RBM3, rather than CIRP, was altered in the skin of diabetic specimens, and the RBM3's overexpression accelerated the cell viability and proliferation of HaCaT cells under high glucose conditions. RBM3 deficiency caused delayed wound healing in RBM3 knockout in diabetic conditions. Moreover. RBM3 enhanced the ERK1/2 signaling pathway, and its inhibitor FR180204 blocked the beneficial effect of RBM3 overexpression on skin wound healing in diabetes.

CONCLUSION

RBM3 activated the ERK1/2 signal to facilitate skin wound healing in diabetes, offering a novel therapeutic target for its treatment.

[Prospective study on the effects of resistance training with elastic band at home on muscle function and walking ability of severely burned children]

Objective: To explore the effects of resistance training with elastic band at home on muscle function and walking ability of severely burned children. Methods: A prospective non-randomized controlled study was conducted. From January 2022 to April 2023, 40 children with severe burns who met the inclusion criteria were admitted to Tongren Hospital of Wuhan University & Wuhan Third Hospital. According to the willingness of the children or their families, the children were assigned to conventional rehabilitation group and combined rehabilitation group. During the study, 8 children dropped out of the study, 17 children were finally included in the conventional rehabilitation group with 6 males and 11 females, aged (8.5±2.4) years, and 15 children were included in the combined rehabilitation group with 5 males and 10 females, aged (9.6±2.5) years. The children in the 2 groups received conventional burn rehabilitation treatment in the hospital, including active and passive activity training, scar massage, and pressure therapy. The children in combined rehabilitation group received resistance training with elastic band of 3 to 5 times per week after discharge, and the children in conventional rehabilitation group received daily activity ability training after discharge. Before home rehabilitation training (1 week before discharge) and 12 weeks after home rehabilitation training, the grip strength was measured using a handheld grip dynamometer, the muscle strengths of the upper and lower limbs were measured using a portable dynamometer for muscle strength, lean body mass was measured by bioelectrical impedance measuring instrument, and the 6-min walking distance was measured. Data were statistically analyzed with independent sample t test, paired sample t test, Mann-Whitney U test, or Fisher's exact probability test. Results: After 12 weeks of home rehabilitation training, the grip strengths of children in combined rehabilitation group and conventional rehabilitation group were (15±4) and (11±4) kg, respectively, which were significantly higher than (10±4) and (9±4) kg before home rehabilitation training (with t values of -9.99 and -11.89, respectively, P values all <0.05); the grip strength of children in combined rehabilitation group was significantly higher than that in conventional rehabilitation group (t=3.24, P<0.05). After 12 weeks of home rehabilitation training, the muscle strengths of upper and lower limbs of children in combined rehabilitation group (with t values of -11.39 and -3.40, respectively, P<0.05) and the muscle strengths of upper and lower limbs of children in conventional rehabilitation group (with t values of -7.59 and -6.69, respectively, P<0.05) were significantly higher than those before home rehabilitation training, and the muscle strengths of upper and lower limbs of children in combined rehabilitation group were significantly higher than those in conventional rehabilitation group (with t values of 3.80 and 7.87, respectively, P<0.05). After 12 weeks of home rehabilitation training, the lean body mass of children in combined rehabilitation group was significantly higher than that before home rehabilitation training (t=0.21, P<0.05). After 12 weeks of home rehabilitation training, the 6-min walking distances of children in conventional rehabilitation group and combined rehabilitation group were significantly longer than those before home rehabilitation training (with t values of -5.33 and -3.40, respectively, P<0.05), and the 6-min walking distance of children in combined rehabilitation group was significantly longer than that in conventional rehabilitation group (t=3.81, P<0.05). Conclusions: Conventional burn rehabilitation treatment in hospital and home resistance training with elastic band for 12 weeks after discharge can significantly improve the muscle function and walking ability of severely burned children.

Circular RNA and intervertebral disc degeneration: unravelling mechanisms and implications

Low back pain (LBP) is a major public health problem worldwide and a significant health and economic burden. Intervertebral disc degeneration (IDD) is the reason for LBP. However, we have not identified effective therapeutic strategies to address this challenge. With accumulating knowledge on the role of circular RNAs in the pathogenesis of IDD, we realised that circular RNAs (circRNAs) may have tremendous therapeutic potential and clinical application prospects in this field. This review presents an overview of the current understanding of characteristics, classification, biogenesis, and function of circRNAs and summarises the protective and detrimental circRNAs involved in the intervertebral disc that have been studied thus far. This review is aimed to help researchers better understand the regulatory role of circRNAs in the progression of IDD, reveal their clinical therapeutic potential, and provide a theoretical basis for the prevention and targeted treatment of IDD.

Esaxerenone Protects against Diabetic Cardiomyopathy via Inhibition of the Chemokine and PI3K-Akt Signaling Pathway

(1) Background: Diabetic cardiomyopathy (DCM) is a unique form of cardiomyopathy that develops as a consequence of diabetes and significantly contributes to heart failure in patients. Esaxerenone, a selective non-steroidal mineralocorticoid receptor antagonist, has demonstrated potential in reducing the incidence of cardiovascular and renal events in individuals with chronic kidney and diabetes disease. However, the exact protective effects of esaxerenone in the context of DCM are still unclear. (2) Methods: The DCM model was successfully induced in mice by administering streptozotocin (55 mg/kg per day) for five consecutive days. After being fed a normal diet for 16 weeks, echocardiography was performed to confirm the successful establishment of the DCM model. Subsequent sequencing and gene expression analysis revealed significant differences in gene expression in the DCM group. These differentially expressed genes were identified as potential targets for DCM. By utilizing the Swiss Target Prediction platform, we employed predictive analysis to identify the potential targets of esaxerenone. A protein-protein-interaction (PPI) network was constructed using the common targets of esaxerenone and DCM. Enrichment analysis was conducted using Metascape. (3) Results: Compared to the control, the diabetic group exhibited impaired cardiac function and myocardial fibrosis. There was a total of 36 common targets, with 5 key targets. Enrichment analysis revealed that the chemokine and PI3K-Akt signaling pathway was considered a crucial pathway. A target-pathway network was established, from which seven key targets were identified. All key targets exhibited good binding characteristics when interacting with esaxerenone. (4) Conclusion: The findings of this study suggest that esaxerenone exhibits a favorable therapeutic effect on DCM, primarily by modulating the chemokine and PI3K-Akt signaling pathway.

HOXB3 promotes trophoblast cell proliferation, invasion, and migration to alleviate preeclampsia via mediating the Notch/Wnt/β-catenin pathway

Preeclampsia (PE) harms a significant number of pregnant women and fetuses. However, because of its complex pathological mechanisms, there is no cure except for delivery. This study identified the impact and mechanisms of action of HOXB3 in PE. The behaviors of HTR-8/SVneo cells were analyzed using a cell counting kit-8, EdU, and transwell assays. The interaction between HOXB3 and Notch1 was assessed using a luciferase reporter and chromatin immunoprecipitation assays. Expression was measured by quantitative real-time polymerase chain reaction, western blotting, and immunofluorescence assays. Additionally, the function of HOXB3 was evaluated in an established rat model of PE. We found that HOXB3 was upregulated in PE. HOXB3 overexpression facilitated trophoblast cell proliferation, migration, and invasion. HOXB3 transcriptionally regulated Notch1 by binding to its promoter. Notch1 knockdown abrogated the functions of HOXB3 and the-catenin pathway in trophoblasts. Suppression of the Wnt/β-catenin pathway abrogated the effects of HOXB3. Additionally, HOXB3 alleviated the symptoms in PE rats. In conclusion, HOXB3 transcriptionally activated Notch1 expression and the-catenin pathway, promoting trophoblast cell proliferation, invasion, and migration, thereby alleviating PE progression. This study provides a novel approach for PE therapy.

Targeting polycomb repressor complex 2-mediated bivalent promoter epigenetic silencing of secreted frizzled-related protein 1 inhibits cholangiocarcinoma progression

BACKGROUND

Cholangiocarcinoma (CCA) refers to a collection of malignancies that are associated with a dismal prognosis. Currently, surgical resection is the only way to cure patients with CCA. Available systemic therapy is limited to gemcitabine plus cisplatin; however, this treatment is palliative in nature. Therefore, there is still a need to explore new effective therapeutic targets to intervene against CCA.

METHODS

We analyzed the expression of EZH2 and the prognosis of patients in CCA. The proliferation, migration and invasion of CCA cells after gene knockdown and overexpression were examined and validated by a xenograft model and a primary CCA mouse model with corresponding gene intervention. Targeting DNA methylation, and RNA-sequencing-based transcriptomic analysis in EZH2 and SUZ12 knockout CCA cells was performed. Bisulfite sequencing polymerase chain reaction (PCR), chromatin immunoprecipitation-quantitative PCR (ChIP-qPCR) and reverse-ChIP assays were performed for research purposes.

RESULTS

Increased expression of EZH2 in CCA exhibited a significantly poorer prognosis. DNA hypomethylation of the promoter and increased mRNA levels of secreted frizzled-related protein 1 (SFRP1) were observed in CCA cells following the inhibition of polycomb repressor complex 2 (PRC2), which was achieved through a knockout of EZH2, SUZ12 and EED, respectively, or treatment with GSK126 and GSK343. Targeting the SFRP1 promoter DNA hypermethylation with dCas9-DNMT3a decreased the mRNA level of SFRP1. The expression of SFRP1 is regulated by both H3K27me3 and DNA methylation and H3K27me3 plays a crucial role in promoting SFRP1 promotor DNA methylation. GSK343 is a small molecule inhibitor that targets the catalytic activity of EZH2. It effectively inhibits the progression and development of subcutaneous xenografts and primary CCA mouse models.

CONCLUSION

Overall, our data strongly suggested that targeting PRC2 promotes the expression of SFRP1, thereby inhibiting the progression of CCA.

KEY POINTS/HEADLIGHTS

Cholangiocarcinoma (CCA) exhibits elevated expression of EZH2, SUZ12 and EED, resulting in increased levels of H3K27me3. Targeting polycomb repressor complex 2 (PRC2) leads to the removal of H3K27me3 from the secreted frizzled-related protein 1 (SFRP1) promoter and DNA hypomethylation, thereby activating the transcription of SFRP1. Inhibiting PRC2, including the use of EZH2 inhibitors, holds promise as a potential strategy for developing anti-cancer drugs for CCA.

Prognostic value of plaque volume combined with CT fractional flow reserve in patients with suspected coronary artery disease

AIM

To investigate the prognostic value of quantitative plaque volume on coronary computed tomography (CT) angiography (CTA) combined with CT fractional flow reserve (CT-FFR) for major adverse cardiac events (MACE) in suspected coronary artery disease (CAD) patients.

MATERIALS AND METHODS

Patients who underwent coronary CTA with clinically suspected CAD were enrolled retrospectively in this study. Patients' baseline, Framingham Risk Score (FRS), coronary CTA plaque assessment, and CT-FFR were analysed retrospectively. Study outcomes included rehospitalisation and MACE (ST-segment elevation myocardial infarction, unstable angina, or non-ST-segment elevation myocardial infarction, revascularisation, and cardiac death).

RESULTS

There were 251 patients in the study, with a follow-up period of 1-6.58 years. Mean age was 61.16 ± 10.45 years and 146 (58%) patients were male. Higher CT-adapted Leaman score and quantitative plaque volume were found in patients with FRS >0.2 regardless of categorical or continuous variables. Coronary scores, quantitative plaque parameters, and CT-FFR were associated with MACE and rehospitalisation in univariate analysis. In model 1, CT-FFR was associated with MACE in multivariate Cox analysis when adjusted for FRS and CT-adapted Leaman score. Quantitative plaque parameters including calcified plaque volume, fibro-fatty plaque volume, low-attenuation plaque volume, non-calcified plaque volume, and total plaque volume were significantly associated with MACE and improved overall prognostic performance in a model adjusted for CT-FFR.

CONCLUSION

Additional quantitative plaque volume and CT-FFR further improve the predictive incremental value based on risk factor scores for prognostic prediction in patients. Adding quantitative plaque volume combined with CT-FFR analysis to anatomical and clinical assessment will be further beneficial to predict patients' prognosis of MACE.

[Preliminary application of recombinase -aided amplification in detection of Clonorchis sinensis metacercariae in freshwater fish]

OBJECTIVE

To evaluate the performance of recombinase-aided amplification (RAA) assay in detection of Clonorchis sinensis metacercariae in freshwater fish samples, so as to provide insights into standardization and field application of this assay.

METHODS

Wild freshwater fish samples were collected in the rivers of administrative villages where C. sinensis-infected residents lived in Jiangyan District, Xinghua County and Taixing County of Taizhou City, Jiangsu Province from June to September 2022. Genomic DNA was extracted from six freshwater fish specimens (5 g each) containing 0, 1, 2, 4, 8 and 16 C. sinensis metacercariae for fluorescent RAA assay, and the diagnostic sensitivity was evaluated. Fluorescent RAA assay was performed with genomic DNA from C. sinensis, Metorchis orientalis, Haplorchis pumilio and Centrocestus formosanus metacercariae as templates to evaluate its cross-reactions. In addition, the detection of fluorescent RAA assay and direct compression method for C. sinensis metacercariae was compared in field-collected freshwater fish samples.

RESULTS

Positive amplification was found in fresh-water fish specimens containing different numbers of C. sinensis metacercariae, and fluorescent RAA assay was effective to detect one C. sinensis metacercaria in 5 g freshwater fish specimens within 20 min. Fluorescent RAA assay tested negative for DNA from M. orientalis, H. pumilio and C. formosanus metacercariae. Fluorescent RAA assay and direct compression method showed 5.36% (93/1 735) and 2.88% (50/1 735) detection rates for C. sinensis metacercariae in 1 735 field-collected freshwater fish samples, with a statistically significant difference seen (χ2 = 478.150, P < 0.001). There was a significant difference in the detection of C. sinensis metacercariae in different species of freshwater fish by both the direct compression method (χ2 = 11.20, P < 0.05) and fluorescent RAA assay (χ2 = 20.26, P < 0.001), and the detection of C. sinensis metacercariae was higher in Pseudorasbora parva than in other fish species by both the direct compression method and fluorescent RAA assay (both P values < 0.05).

CONCLUSIONS

Fluorescent RAA assay has a high sensitivity for detection of C. sinensis metacercariae in freshwater fish samples, and has no cross-reactions with M. orientalis, H. pumilio or C. formosanus metacercariae. Fluorescent RAA assay shows a higher accuracy for detection of C. sinensis infections in field-collected freshwater fish than the direct compression method.

Biomechanical evaluation of a novel anterior transpedicular screw-plate system for anterior cervical corpectomy and fusion (ACCF): a finite element analysis

Background and objective: Cervical fusion with vertebral body screw (VBS)-plate systems frequently results in limited biomechanical stability. To address this issue, anterior transpedicular screw (ATPS) fixation has been developed and applied preliminarily to multilevel spinal fusion, osteoporosis, and three-column injury of the cervical spine. This study aimed to compare the biomechanical differences between unilateral ATPS (UATPS), bilateral ATPS (BATPS), and VBS fixation using finite element analysis. Materials and methods: A C6 corpectomy model was performed and a titanium mesh cage (TMC) and bone were implanted, followed by implantation of a novel ATPS-plate system into C5 and C7 to simulate internal fixation with UATPS, BATPS, and VBS. Internal fixation with UATPS comprises ipsilateral transpedicular screw-contralateral vertebral body screw (ITPS-CVBS) and cross transpedicular screw-vertebral body screw (CTPS-VBS) fixations. Mobility, the maximal von Mises stress on TMC, the stress distribution and maximal von Mises stress on the screws, and the maximum displacement of the screw were compared between the four groups. Results: Compared with the original model, each group had a reduced range of motion (ROM) under six loads. After ACCF, the stress was predominantly concentrated at two-thirds of the length from the tail of the screw, and it was higher on ATPS than on VBS. The stress of the ATPS from the cranial part was higher than that of the caudal part. The similar effect happened on VBS. The screw stress cloud maps did not show any red areas reflective of a concentration of the stress on VBS. Compared with VBS, ATPS can bear a greater stress from cervical spine movements, thus reducing the stress on TMC. The maximal von Mises stress was the lowest with bilateral transpedicular TMC and increased with cross ATPS and with ipsilateral ATPS. ITPS-CVBS, CTPS-VBS, and BATPS exhibited a reduction of 2.3%-22.1%, 11.9%-2.7%, and 37.9%-64.1% in the maximum displacement of screws, respectively, compared with that of VBS. Conclusion: In FEA, the comprehensive stability ranked highest for BATPS, followed by CTPS-VBS and ITPS-CVBS, with VBS demonstrating the lowest stability. Notably, utilizing ATPS for fixation has the potential to reduce the occurrence of internal fixation device loosening after ACCF when compared to VBS.

Use of patient-derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Postoperative adjuvant chemotherapy (AC) for poor responders to neoadjuvant chemoradiotherapy (nCRT) remains debatable among patients with locally advanced rectal cancer (LARC), necessitating biomarkers to accurately predict the benefits of AC. This study aimed to develop a patient-derived tumor organoid (PDTO) platform to predict the benefit of AC in LARC patients showing poor nCRT response. PDTOs were established using irradiated rectal cancer specimens with poor nCRT responses, and their sensitivity to chemotherapy regimens was tested. The half-maximal inhibitory concentration (IC50) value for the PDTO drug test was defined based on the clinical outcomes, and the accuracy of the PDTO prognostic predictions was calculated. Predictive models were developed and validated using the PDTO drug test results. Between October 2018 and December 2021, 86 PDTOs were successfully constructed from 138 specimens (success rate 62.3%). The optimal IC50 cut-off value for the organoid drug test was 39.31 μmol/L, with a sensitivity of 84.75%, a specificity of 85.19%, and an accuracy of 84.88%. Multivariate Cox regression analysis revealed that the PDTO drug test was an independent predictor of prognosis. A nomogram based on the PDTO drug test was developed, showing good prognostic ability in predicting the 2-year and 3-year disease-free survivals (AUC of 0.826 [95% CI, 0.721-0.931] and 0.902 [95% CI, 0.823-0.982], respectively) and overall survivals (AUC of 0.859 [95% CI, 0.745-0.973] and 0.885 [95% CI, 0.792-0.978], respectively). The PDTO drug test can predict the benefit of postoperative AC in poor responders with LARC to nCRT.

Observation of New Baryons in the Ξ_{b}^{-}π^{+}π^{-} and Ξ_{b}^{0}π^{+}π^{-} Systems

The first observation and study of two new baryonic structures in the final state Ξ_{b}^{0}π^{+}π^{-} and the confirmation of the Ξ_{b}(6100)^{-} state in the Ξ_{b}^{-}π^{+}π^{-} decay mode are reported using proton-proton collision data collected by the LHCb experiment, corresponding to an integrated luminosity of 9  fb^{-1}. In addition, the properties of the known Ξ_{b}^{*0}, Ξ_{b}^{'-} and Ξ_{b}^{*-} resonances are measured with improved precision. The new decay mode of the Ξ_{b}^{0} baryon to the Ξ_{c}^{+} π^{-} π^{+} π^{-} final state is observed and exploited for the first time in these measurements.

Precision Measurement of CP Violation in the Penguin-Mediated Decay B_{s}^{0}→ϕϕ

A flavor-tagged time-dependent angular analysis of the decay B_{s}^{0}→ϕϕ is performed using pp collision data collected by the LHCb experiment at the center-of-mass energy of 13 TeV, corresponding to an integrated luminosity of 6  fb^{-1}. The CP-violating phase and direct CP-violation parameter are measured to be ϕ_{s}^{ss[over ¯]s}=-0.042±0.075±0.009  rad and |λ|=1.004±0.030±0.009, respectively, assuming the same values for all polarization states of the ϕϕ system. In these results, the first uncertainties are statistical and the second systematic. These parameters are also determined separately for each polarization state, showing no evidence for polarization dependence. The results are combined with previous LHCb measurements using pp collisions at center-of-mass energies of 7 and 8 TeV, yielding ϕ_{s}^{ss[over ¯]s}=-0.074±0.069  rad and |λ|=1.009±0.030. This is the most precise study of time-dependent CP violation in a penguin-dominated B meson decay. The results are consistent with CP symmetry and with the standard model predictions.

Clinical evaluation of metagenomic next-generation sequencing in unbiased pathogen diagnosis of urinary tract infection

BACKGROUND

Early availability of pathogen identification in urinary tract infections (UTIs) has critical importance in disease management. Metagenomic next-generation sequencing (mNGS) has the potential to transform how acute and serious infections are diagnosed by offering unbiased and culture-free pathogen detection. However, clinical experience with application of the mNGS test is relatively limited.

METHODS

We therefore established a MinION-based mNGS pathogens diagnostic platform and evaluated its potential for clinical implementation in UTIs with clinical samples. 213 urine samples from patients with suspected UTIs were included and subjected to mNGS testing using the MinION platform. mNGS results were compared to the gold standard of clinical culture and composite standard of combining clinical testing, confirmatory qPCR testing, and clinical adjudication by doctors.

RESULTS

The mNGS exhibited a sensitivity of 81.4% and a specificity of 92.3%, along with a positive predictive value of 96.6%, a negative predictive value of 64.9%, and an overall accuracy of 84.4%, all of which were determined based on the gold standard of routine culture results. When assessed against the composite standard, the sensitivity and specificity both increased to 89.9% and 100%, respectively, while the accuracy rose to 92.4%. Notably, the positive predictive value and negative predictive value also saw improvements, reaching 100% and 76.8%, respectively. Moreover, this diagnostic platform successfully identified dsDNA viruses. Among the 65 culture-negative samples, the viral detection rate reached 33.8% (22/65) and was subsequently validated through qPCR. Furthermore, the automatic bioinformatics pipeline we developed enabled one-click analysis from data to results, leading to a significant reduction in diagnosis time.

CONCLUSION

These results demonstrate that the pathogen detection performance of mNGS is sufficient for diagnostic testing in clinical settings. As the method is generally unbiased, it can improve diagnostic testing of UTIs and other microbial infections.

Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology

Osteosarcoma (OS) is a multifactorial bone malignancy that accounts for most cancers in children and adolescents. Formononetin has been proven to exhibit various pharmacological effects including anti-tumor, anti-obesity, anti-inflammation, and neuroprotective effects. Few studies have examined the pharmacological activities of formononetin in OS treatment, but the mechanism has not yet been completely elucidated. Network pharmacology is a new method based on the theory of system biology for analyzing the network of biological systems and selecting specific signal nodes for multi-target drug molecular design. Here, we used network pharmacology to explore the possible mechanism of formononetin in OS treatment. Human OS cell line MG63 was processed with four concentrations (0, 2, 5, 8 μg/mL) of formononetin. Subsequently, an MTT assay was performed to test cell proliferation and a scratch test was used to evaluate the migration ability of cancer cells. Caspase-3, p53, p21, and bcl-2 expression levels incubated with different concentrations of formononetin in MG63 cells were determined using Western blotting. After treated with formononetin for 48 h, MG63 cells exhibited marked apoptosis. The results revealed that certain concentrations of formononetin significantly exerted inhibitory effects on MG63 cell proliferation. Furthermore, formononetin decreased the bcl-2 level in MG63 cells but increased caspase-3, p21, and p53 levels in a concentration-dependent manner. Additionally, formononetin suppressed the expression of SATB2. Therefore, formononetin could dose-dependently inhibit MG63 cell proliferation and induce apparent cell apoptosis, providing a candidate treatment for OS, whereas SATB2 could be a potential prognostic biomarker for screening OS and therapeutic target of formononetin.

Broadband near-infrared amplified spontaneous emission of Er3+-doped germanate glass fiber

Er3+-doped glass and fiber are very attractive for near-infrared (NIR) lasers and photonic applications. In this work, the full width at half maximum (FWHM) of NIR fluorescence emission of the Er3+-doped germanate glass can be broadened from 72 to 99 nm when Al2O3 was added. In addition, the spectroscopic properties, including absorption and emission spectra, Judd-Ofelt intensity parameters, absorption and emission cross sections, gain coefficient, and fluorescence lifetime, of the Al2O3-modified germanate glass were systematically investigated. What is more, silicate-clad heavily Er3+-doped germanate core multimaterial fibers were successfully drawn by a rod-in-tube method. Notably, broadband NIR amplified spontaneous emission (ASE) with an FWHM of 120 nm was achieved in this new fiber. To the best of our knowledge, this is the largest FWHM reported for Er3+-doped germanate glass fibers. These results suggest that the as-drawn Er3+-doped germanate glass fiber with superior performances is a promising candidate for broadband optical amplification.

Measurement of the Λ_{b}^{0}→Λ(1520)μ^{+}μ^{-} Differential Branching Fraction

The branching fraction of the rare decay Λ_{b}^{0}→Λ(1520)μ^{+}μ^{-} is measured for the first time, in the squared dimuon mass intervals q^{2}, excluding the J/ψ and ψ(2S) regions. The data sample analyzed was collected by the LHCb experiment at center-of-mass energies of 7, 8, and 13 TeV, corresponding to a total integrated luminosity of 9  fb^{-1}. The result in the highest q^{2} interval, q^{2}>15.0  GeV^{2}/c^{4}, where theoretical predictions have the smallest model dependence, agrees with the predictions.

Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis

BACKGROUND

The Global COVID Vaccine Safety (GCoVS) project was established in 2021 under the multinational Global Vaccine Data Network (GVDN) consortium to facilitate the rapid assessment of the safety of newly introduced vaccines. This study analyzed data from GVDN member sites on the background incidence rates of conditions designated as adverse events of special interest (AESI) for COVID-19 vaccine safety monitoring.

METHODS

Eleven GVDN global sites obtained data from national or regional healthcare databases using standardized methods. Incident events of 13 pre-defined AESI were included for a pre-pandemic period (2015-19) and the first pandemic year (2020). Background incidence rates (IR) and 95% confidence intervals (CI) were calculated for inpatient and emergency department encounters, stratified by age and sex, and compared between pre-pandemic and pandemic periods using incidence rate ratios.

RESULTS

An estimated 197 million people contributed 1,189,652,926 person-years of follow-up time. Among inpatients in the pre-pandemic period (2015-19), generalized seizures were the most common neurological AESI (IR ranged from 22.15 [95% CI 19.01-25.65] to 278.82 [278.20-279.44] per 100,000 person-years); acute disseminated encephalomyelitis was the least common (<0.5 per 100,000 person-years at most sites). Pulmonary embolism was the most common thrombotic event (IR 45.34 [95% CI 44.85-45.84] to 93.77 [95% CI 93.46-94.08] per 100,000 person-years). The IR of myocarditis ranged from 1.60 [(95% CI 1.45-1.76) to 7.76 (95% CI 7.46-8.08) per 100,000 person-years. The IR of several AESI varied by site, healthcare setting, age and sex. The IR of some AESI were notably different in 2020 compared to 2015-19.

CONCLUSION

Background incidence of AESIs exhibited some variability across study sites and between pre-pandemic and pandemic periods. These findings will contribute to global vaccine safety surveillance and research.

High Dose Hyperfractionated Thoracic Radiotherapy vs. Standard Dose for Limited Stage Small-Cell Lung Cancer: A Multicenter, Open-Label Randomized, Phase 3 Trial

PURPOSE/OBJECTIVE(S)

Limited stage small-cell lung cancer (LS-SCLC) is associated with poor prognosis. We aimed to assess the efficacy and safety of high-dose, hyperfractionated thoracic radiotherapy of 54 Gy in 30 fractions compared with standard dose (45 Gy in 30 fractions) as a first-line treatment for LS-SCLC.

MATERIALS/METHODS

The study was an open-label, randomized, phase 3 trial, done at 16 public hospitals in China. Key inclusion criteria were patients aged 18-70 years, with previously histologically or cytologically confirmed LS-SCLC, previously untreated or received 1-2 courses of intravenous cisplatin (75 mg/m²of body-surface area, on day 1 or divided into two days of each cycle) or carboplatin (area under the curve of 5 mg/mL per min, day 1 of each cycle)and intravenous etoposide (100 mg/m²of body-surface area, on days 1-3 of each cycle), and an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.Eligible patients were randomly assigned (1:1) to receive volumetric-modulated arc radiotherapy (VMAT) of 45 Gy in 30 fractions or the simultaneous integrated boost VMAT (SIB-VMAT) of 54 Gy in 30 fractions to the primary lung tumor and lymph node metastases starting 0-42 days after the first chemotherapy course. Both groups of patients received thoracic radiotherapy twice per day and 10 fractions per week. Prophylactic cranial radiation (PCI, 25 Gy in 10 fractions) was implemented to patients with responsive disease. The primary endpoint was overall survival. Safety was analyzed in the as-treated population.

RESULTS

Between June 30, 2017, and April 6, 2021, 224 eligible patients were enrolled and randomly assigned to 54 Gy (n = 108) or 45 Gy (n = 116). Median follow-up for the primary analysis was 45 months (IQR 41-48). Median overall survival was significantly improved in the 54 Gy group (62.4 months) compared with the 45 Gy group (43.1 months; p = 0.001). Median progression-free survival was significantly improved in the 54 Gy group (30.5 months) compared with the 45 Gy group (16.7 months; p = 0.044). The most common grade 3-4 adverse events were neutropenia (30 [28%] of 108 patients in the 54 Gy group vs 27 [23%] of 116 patients in the 45 Gy group), neutropenic infections (6 [6%] vs 2 [2%]), thrombocytopenia (13 [12%] vs 12 [10%]), anemia (6 [6%] vs 4 [3%]), and esophagitis (1 [1%] vs 3 [3%]). Treatment-related serious adverse events occurred in 9 [8%] patients in the 54 Gy group and 16 [14%] patients in the 45 Gy group. There were one treatment-related deaths in 54 Gy group (myocardial infarction).

CONCLUSION

Compared with standard thoracic radiotherapy dose of 45 Gy, the high dose of 54 Gy improved overall survival and progression-free survival without increasing toxicities in patients with LS-SCLC, supporting twice-daily hyperfractionated thoracic radiotherapy of 54 Gy with concurrent chemotherapy is an alternative treatment option for LS-SCLC. This study is complete and registered with ClinicalTrials.gov, NCT03214003.

Radical Chemoradiotherapy vs. Radical Surgery plus Adjuvant Chemotherapy or Chemoradiotherapy in Locally Advanced Primary Small Cell Carcinoma of the Esophagus: A Multicenter Retrospective Study in China

PURPOSE/OBJECTIVE(S)

The purpose was to compare the treatment outcomes of radical chemoradiotherapy versus radical surgery plus adjuvant chemotherapy or chemoradiotherapy in locally advanced primary small cell carcinoma of the esophagus (LA-PSCCE). The hypothesis was that radical chemoradiotherapy had better overall survival (OS) than radical surgery plus adjuvant chemotherapy or chemoradiotherapy.

MATERIALS/METHODS

This large-scale multicenter retrospective study in China enrolled patients with newly diagnosed LA-PSCCE (T3-4N0M0 or TanyN+M0, AJCC 8th edition) from 2008 to 2021. According to different curative treatment approaches, patients were divided into two groups: radical chemoradiotherapy (group: CRT), and radical surgery following adjuvant chemotherapy or chemoradiotherapy (group: S + CT/CRT). The propensity score match (PSM) was applied to reduce the effect of confounding biases in clinicopathological characteristics (age, gender, KPS, tumor location, tumor length, and cTNM stage). Univariate Cox-regression analysis and Kaplan-Meier curve were calculated for OS. Statistical results were summarized as hazard ratio (HR), 95% confidence interval (CI) and P value. A two-sided P < 0.05 was regarded to be statistically significant.

RESULTS

A total of 291 patients with a median follow-up of 4.3 years were retrospectively enrolled. After PSM analysis, 94 and 94 patients were eventually included in group CRT and S + CT/CRT, respectively. Group CRT demonstrated a significantly superior survival than group S + CT/CRT (HR, 0.63; 95% CI, 0.43-0.91; P = 0.01), with a 3-year OS of 49.5% and 27.8% (P = 0.02), respectively. In secondary analysis, patients treated with radical chemoradiotherapy consistently showed significant survival benefit than those with radical surgery plus adjuvant chemoradiotherapy (HR, 0.4; 95% CI, 0.21-0.79; P = 0.008).

CONCLUSION

For patients with newly diagnosed LA-PSCCE, radical chemoradiotherapy should be a preferred recommendation in real-world clinical practice.

Delta-Radiomics Guides Adaptive De-Intensification after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma in the IMRT Era

PURPOSE/OBJECTIVE(S)

In the setting of intensity-modulated radiotherapy (IMRT) and induction chemotherapy (IC), the benefits from concurrent chemotherapy remained controversial for locoregionally advanced nasopharyngeal carcinoma (LANPC). This study aimed to construct a delta-radiomics model for benefit prediction and patient selection for omitting concurrent chemotherapy.

MATERIALS/METHODS

Between December 2009 and December 2015, a total of 718 patients with LANPC treated with IC+IMRT or IC+concurrent chemoradiotherapy (CCRT) were retrospectively enrolled and randomly assigned to a training set (n = 503) and a validation set (n = 215). Radiomic features were extracted from magnetic resonance images of pre-IC and post-IC. Interclass correlation coefficients and Pearson correlation coefficients were calculated to select robust radiomic features. After univariate Cox analysis, a delta-radiomics signature was built using the LASSO-Cox regression. A nomogram incorporating the delta-radiomics signature and clinical prognostic factors was then developed and evaluated for calibration and discrimination. Risk stratification by the nomogram was evaluated by Kaplan-Meier methods. The primary outcome was overall survival (OS).

RESULTS

The delta-radiomics signature, which comprised 19 selected features, was independently associated with prognosis. It yielded an area under the receiver operating characteristic curve (AUC) of 0.77 (95% confidence interval [CI] 0.71 to 0.82) for the training set and 0.71 (95% CI 0.61 to 0.81) for the validation set. The nomogram composed of the delta-radiomic signature, age, T category, N category, pre-treatment Epstein-Barr virus DNA, and treatment showed great calibration and discrimination performance with an AUC of 0.80 (95% CI 0.75 to 0.85) for the training set and 0.75 (95% CI 0.64 to 0.85) for the validation set. Risk stratification by the nomogram excluding the treatment variable resulted in two risk groups with distinct OS. Significant better outcomes were observed in the high-risk patients with IC+CCRT compared to those with IC+IMRT (5-year OS: 73.8% vs. 61.4% in the training set and 85.8% vs. 65.6% in the validation set; all log-rank p < 0.05), while comparable outcomes between IC+CCRT and IC+IMRT were shown for the low-risk patients (95.8% vs. 95.8% in the training set and 92.2% vs. 88.3% in the validation set; all log-rank p > 0.05).

CONCLUSION

The delta-radiomics signature was identified as an independent indicator of LANPC. Integrating clinical predictors with the delta-radiomics signature, the radiomics-based nomogram could predict individual's survival outcomes and benefits from concurrent chemotherapy after IC for LANPC. Low-risk patients with LANPC determined by the nomogram may be potential candidates for omission of concurrent chemotherapy following IC in the IMRT era.

Safety and Efficacy Analysis of Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Treated with SHR-1316 Plus Chemotherapy and Sequential Chest Radiotherapy as First-Line Therapy from a Phase II Trial

PURPOSE/OBJECTIVE(S)

CAPSTONE-1, a phase 3 trial, showed that SHR-1316 (PD-L1 antibody) combined with standard first-line chemotherapy could prolong overall survival (OS) in patients (pts) with ES-SCLC. The CREST trial reported consolidative thoracic radiotherapy (TRT) of 30 Gy in 10 fractions provided a 10% 2-year OS benefit and more intensive TRT should be investigated in ES-SCLC. In the era of immunotherapy, the role of TRT also needs further exploration. Therefore, we designed this clinical trial to investigate the efficacy and safety of SHR-1316 plus first-line chemotherapy followed by TRT combined with SHR-1316.

MATERIALS/METHODS

Key inclusion criteria were pts aged 18-75 years, with previously untreated histologically or cytologically confirmed ES-SCLC, and an ECOG performance status of 0-1. Eligible pts would receive 4∼6 cycles of SHR-1316 (20mg/kg, D1, q3w) combined with EP/EC (etoposide, 100mg/m2, D1-5, q3w and cisplatin, 75mg/m², D1-3, q3w or carboplatin, AUC = 5, D1, q3w), followed by SHR-1316 combined with TRT (≥3 Gy*10 f or ≥2 Gy*25 f, involved-field irradiation), and then the maintenance therapy with SHR-1316 until disease progression or intolerable adverse events (AEs). The main endpoints included ORR, PFS and safety.

RESULTS

From October 2020 to January 2023, 33 pts received SHR-1316 and sequential consolidative TRT. Among them, 19 pts received high-dose TRT (>3 Gy*10 f or ≥2 Gy*25 f) and 14 pts received low-dose TRT (≤3 Gy*10 f or<2 Gy*25 f). The median age was 62 (range: 38-73). Most pts were male (28, 84.8%), former smokers (22, 66.7%) with an ECOG performance status 1 (32, 97%). Ten (30.3%) pts were diagnosed with brain metastasis and 10 (30.3%) pts had liver metastasis at baseline. At the data cutoff date, 9 pts remained on treatment, the average number of treatment cycles was 9.2. 33 pts had at least one 1 post-treatment tumor assessment. The confirmed ORR and DCR were 90.9% (30/33) and 100% (33/33) in all pts, were 89.5% (17/19) and 100% (19/19) in high-dose TRT group, and were 92.9% (13/14) and 100% (14/14) in low-dose TRT group. The median PFS was 10.2(CI: 5.8∼14.7) months in all pts, was 7 (CI: 3.8∼10.2) months in high-dose TRT group and 10.4 (CI: 8.4∼12.3) months in low-dose TRT group. AEs occurred in 27 (81.8%) pts and grade 3 or 4 AEs occurred in 20 (60.6%) pts. The most common grade 3 or 4 AEs included neutropenia (15, 45.5%), leukopenia (8, 24.2%), lymphocytopenia (5, 15.2%), pneumonia (3, 9.1%), anemia (3, 9.1%) and thrombocytopenia (2, 6.1%).

CONCLUSION

SHR-1316 plus chemotherapy and sequential TRT as first-line therapy for ES-SCLC showed promising efficacy and acceptable safety. There is no significant difference between high-dose and low-dose TRT groups in terms of safety and efficacy according to current data.

Could Residual Disease Irradiation be Better than Involved Field Irradiation for Limited-Stage Small Cell Lung Cancer? A Failure Pattern Analysis

PURPOSE/OBJECTIVE(S)

For limited-stage small cell lung cancer (LS-SCLC), the thoracic radiotherapy (TRT) plays a vital role. Previous clinical research showed that for the TRT could be limited to the postchemotherapy tumor volume and the positive prechemotherapy lymph node regions. Involved field irradiation (IFI) could be routinely applied. However, the optimum radiation field design remains controversial. In the present study, we retrospectively analyzed the patterns of failure in LS-SCLC patients receiving residual disease irradiation (RDI) in radiotherapy.

MATERIALS/METHODS

A total of 47 patients with LS-SCLC treated with RDI with sequent or concurrent chemotherapy were enrolled in this study. The gross tumor volume (GTV) defined as residual volumes of positive node and primary tumor of the post-chemotherapy. The clinical target volume (CTV) included GTV with a margin 0.5 cm. Planning target volume (PTV) involved CTV with a margin 0.5 cm. RFI consisted of 1.5 grays (Gy) twice daily in 30 fractions up to a total dose of 45 Gy or 2.0 Gy daily up to 60 Gy. Treatment failures were divided into local and distant failures, and local recurrences were classified into inside RDI(IN-RDI), between RDI and IFI(RDI-IFI), and outside IFI(OUT-IFI).

RESULTS

Among the 46 patients with detailed follow-up data for recurrences, 36 (78.3%) experienced recurrences, with 16 (34.8%) being local recurrence, and 29 (63.0%) being distant failure. For the 16 patients with local recurrences, 10, 5, and 1 were IN-RDI, OUT-IFI, and RDI-IFI recurrences, respectively.

CONCLUSION

Residual disease irradiation (RDI) is feasible for LS-SCLC treated with sequent or concurrent chemotherapy and does not compromise failure inside the involved region.

Disease and Toxicity Outcomes after Salvage Radiotherapy (SRT) for Biochemically Recurrent Prostate Cancer (PC) for Patients Enrolled in a Phase II, Open Label Trial Investigating Neoadjuvant Chemohormonal Therapy Followed by Radical Prostatectomy (RP)

PURPOSE/OBJECTIVE(S)

Men with metastatic hormone sensitive prostate cancer have improved progression free and overall survival (PFS/OS) when treated with docetaxel and androgen deprivation therapy (ADT). Our institution conducted a phase II trial (UW17009) investigating the addition of three cycles of neoadjuvant docetaxel and ADT to RP in men with high-risk prostate cancer. Here we report toxicity and freedom from biochemical recurrence (FFBCR) for patients treated with SRT following participation in this trial.

MATERIALS/METHODS

Between January 17, 2018 and August 10, 2021, 28 patients enrolled on UW17009. Patients who had a recurrence and received SRT were identified. Toxicity was assessed using modified LENT (Late Effects of Normal Tissues)/RTOG (Radiation Therapy Oncology Group) criteria, and time to recurrence following SRT was determined for each patient. Additionally, the months of ADT received by each patient was recorded. FFBCR was then determined for this cohort using the method of Kaplan and Meier.

RESULTS

Of 28 patients enrolled on UW17009, 20 (71%) had BCR after RP. Of these, 19 received SRT, representing 68% of the patients enrolled on the trial. The rates of acute grade 1 and grade 2 GU toxicity with SRT were 37% (7) and 53% (10), respectively. The rates of acute grade 1 and grade 2 GI toxicity with SRT were 32% (6) and 37% (7), respectively. On patient experienced a grade 4 genitourinary toxicity during SRT. There were no acute grade 3 or grade 5 toxicities. The rates of late grade 1 and grade 2 GU toxicity were 16% (3) and 11% (2), respectively. The rates of late grade 1 and grade 2 GI toxicity were 11% (2) and 5% (1), respectively. There was 1 (5%) late grade 3 GU toxicity. There were no late grade 3-5 GI toxicities, or late grade 4-5 GU toxicities. The average duration of ADT after prostatectomy was 15 months (range: 0-37 months). According to the method of Kaplan and Meier, mean FFBCR after SRT was 34.0 months at a median of 37.8 months. Median FFBCR had not yet been reached. At the time of analysis, 13 patients remained free from biochemical recurrence after SRT.

CONCLUSION

Rates of biochemical recurrence and SRT following neoadjuvant docetaxel and ADT and then RP were consistent with historical data, as was the rate of successful SRT. Toxicities were also consistent with historical data, though there was notably one acute grade 4 GU toxicity.

Effect of Histopathological Regression of Tumor and Lymph Node on the Progression of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy

PURPOSE/OBJECTIVE(S)

To investigate the regression of tumor and lymph node after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma (ESCC) and their impact on progression-free survival (PFS).

MATERIALS/METHODS

We enrolled 181 patients with localized esophageal cancers (cT2-4, Nx, M0) who underwent neoadjuvant radiochemotherapy followed by surgery for esophageal carcinoma (EC) between March 2016 and December 2021. Patients clinical factors including age, gender, tumor location, cT stage, cN stage, cTNM stage, chemotherapy regimen, total radiation dose were collected. The pathologist evaluated the response of tumors and lymph nodes removed during esophagectomy, including ypT stage, ypN stage, complete pathological response (PCR) status, and tumor regression grading (TRG) stage. The Kaplan-Meier method was used for univariate analyses of PFS. Multivariate analysis of prognostic variables that showed significant association were further assessed by Cox proportional hazard model.

RESULTS

The median PFS was 6.6 months. The primary tumors of 134 (74%) patients had pathological remission. The metastatic lymph node of 100 (55.2%) patients had pathological remission. Complete pathological remission was observed in 93(48.7%) patients. Univariate survival analysis identified cT stage (P:0.027), pT (P:0.001), pN (P:0.0001), TRG stage (P:0.0001), PCR status (P:0.001) as significant prognostic factors. Cox regression analysis identified dichotomized ypN (P:0.028) and TRG stage (P:0.034) as significant independent prognostic parameters.

CONCLUSION

ypN and TRG stage were significant prognostic parameters for PFS in patients with neoadjuvant chemoradiotherapy for ESCC.

The Applicability of the AJCC TNM Staging 8th Edition to Esophageal Small-Cell Carcinoma: A Multicenter Retrospective Trial from China

PURPOSE/OBJECTIVE(S)

Small cell carcinoma of the esophagus (SCCE) is a rare type of esophageal cancer, the incidence of it is only 0.1% to 2.4% in all cases of esophageal cancer. However, the optimal disease staging system has not yet been defined. To comprehensively explore the impact of AJCC TNM Staging 8th edition on survival outcome of SCCE.

MATERIALS/METHODS

From January 2007 to December 2020, 909 patients with SCCE who had completed TNM staging from 14 cancer centers in China were retrospectively examined. Univariate survival rate analyses were estimated using the Kaplan and Meier method, with comparisons made between groups by the log-rank test. All statistical analyses were conducted using SPSS 25 statistical software. Statistical significance was assumed for a two-tailed p value less than 0.05.

RESULTS

TNM stage also was a statistically significant prognostic factor for OS and PFS in SCCE(p<0.001). Increasing clinical T category using the AJCC8 TNM staging system resulted in progressively poorer survival in patients who did not have metastatic (M0) involvement(p<0.01). However, the results of pairwise comparisons showed no significant differences in survival between patients with adjacent phases except for those between T3 versus T2 (p<0.0001). N staging also showed significant influence on OS, and with significant difference between successive stages (p<0.05) except that between the survival rates of N1 and N2 cases (p = 0.00758). Similar to t category, increasing M category was associated with progressively worse survival. The T and N staging confirmed significant influence on PFS in the SCCE patients (p<0.001).

CONCLUSION

AJCC TNM Staging 8th edition criteria for SCCE patients has a high prognostic impact. Therefore, it is applied to clinical practice and future therapeutic trials.